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ABSTRACT 
PRESENCE OF PSYCHOSOCIAL SYMPTOMS IN YOUNG ADULT STROKE 
SURVIVORS POST-ACUTE THROMBECTOMY FOR ISCHEMIC STROKE 
by 
KAREN B. SEAGRAVES 
 Young adults are the fastest growing population of stroke patients. Current 
treatments enable physicians to reverse hyper-acute large vessel ischemic stroke, and 
young adult stroke survivors (YASS) are increasingly discharged directly home with few 
to no apparent neurological deficits. No studies have examined the psychosocial 
experiences these YASS have once they are home and whether these experiences are 
associated with stroke-specific quality of life (SSQOL). The purpose of this study was to 
describe YASS post-stroke symptoms, their understanding and perception of those 
symptoms, and to examine relationships among psychosocial variables: anxiety, 
depression, fatigue, illness threat perceptions and SSQOL. 
 A cross-sectional, exploratory design was used. YASS 18-55 years of age and 1-
18 months post-stroke who received a thrombectomy at a metropolitan, comprehensive 
stroke center and discharged directly home were recruited. Demographic and clinical data 
(e.g. NIHSS, mRS scores) were collected from the hospital’s electronic medical record. 
Participants completed questionnaires to assess psychosocial variables using an online or 
paper survey. Data were analyzed using SPSS version 25. Descriptive statistics and  
Spearman rho correlations were performed. 
 Participants (N = 14) had a mean age 45 years (SD = 6.2), were 4-18 months post-
stroke, 71% female, 57% Black, and had discharge NIHSS scores indicating minimal 
  
 
vii 
 
neurological deficits (M = 2, SD = 2.6). Five participants were identified as having 
clinically severe fatigue; three had borderline cases. There was one case of clinically 
significant anxiety with one borderline case, and one case of clinically significant 
depression with three borderline cases. All participants perceived some level of threat of 
the symptoms they were experiencing, and overall SSQOL was decreased. Higher levels 
of fatigue, anxiety, depression and illness perception threat were significantly related to 
lower SSQOL. 
 In spite of being discharged home with minimal to no physical deficits, this 
sample of YASS described psychosocial symptoms, notably fatigue, that may impact 
recovery and transition back to the community. Further research is needed with a larger 
sample of these YASS to evaluate their psychosocial needs. Symptom assessments, 
provision of education, resources and ongoing support before and after discharge home 
may be beneficial. 
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CHAPTER I 
INTRODUCTION 
Young adults are the fastest growing population of stroke patients. From 2000-
2010, 10% of strokes in the United States occurred in adults between the ages of 18-50 
years (Mozaffarian et al., 2015). This age range is comprised of adults who are in their 
productive work years, often raising children and caring for elderly parents. Between 
1990-2015, of all neurological disorders, stroke accounted for the highest percentage of 
disability-adjusted life years worldwide (Global Burden of Disease, 2017). The potential 
for prolonged recovery time, decades of living with disability, the higher economic cost 
of stroke care, and the looming prospect of future stroke can all be devastating sequelae 
of stroke in the young adult. Although stroke mortality has declined from the 3rd to the 5th 
leading cause of death in the United States because of technological advances, stroke 
remains the leading cause of adult disability (Mozaffarian, 2015). However, new 
technologies may further help in preventing or minimizing disability (Powers et al., 
2018).  
New technological advances now enable physicians to halt an acute stroke, restore 
blood flow, and prevent or minimize permanent damage to the brain. In 2015, at the 
American Heart Association/ American Stroke Association (AHA/ASA) International 
Stroke Conference, the world’s leading authorities on stroke announced that endovascular 
thrombectomy for large vessel acute ischemic stroke is supported by level 1A evidence 
and is the new standard of care for patients within 6 hours of stroke onset (Saver et al., 
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2015). In March, 2017, the DAWN trial, which investigated thrombectomy for large 
vessel occlusion in the 6 to 24-hour window from stroke ictus, was stopped early for 
efficacy after interim review (Nogueira et al., 2017). The DAWN trial demonstrated that 
with the appropriate clinical exam, imaging, and device utilization, that wake-up or late-
discovery stroke patients (6 to 24 hours from onset) undergoing thrombectomy, had up to 
73% better outcomes than those not treated (Nogueira et al., 2017). Results from the 
National Institutes of Health funded DEFUSE3 trial were announced at the 2018 
AHA/ASA International Stroke Conference, providing additional evidence that late 
treatment with thrombectomy, up to 16 hours post-onset, reduces death and disability 
(Albers et al., 2018). As a result of the above trials, there is increasing evidence of better 
outcomes (reduced mortality, less physical disability, increase in functional 
independence), wider availability of the endovascular procedures for stroke, and clinical 
acceptance of these treatments. Compared to older adults, young adults may benefit more 
from these new technologies and expanded time window, because young adults are less 
likely to be excluded from treatment for pre-existing disability or dementia, based on the 
current trials’ inclusion and exclusion criteria. Therefore, more young adults experiencing 
large vessel stroke are receiving treatment, and rapidly recovering from severe 
neurological symptoms. As a result, many of these young adult stroke survivors (YASS) 
are discharged directly from the hospital to home because they have few to no apparent 
neurological deficits. 
Problem 
YASS who escape visible neurological injury, as measured by the National 
Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) scores may 
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be discharged to home from the acute hospital setting, and often do not require 
rehabilitation for physical disabilities and follow up (Goyal et al., 2016; Plath et al., 
2016). As a result, there is little opportunity to screen these YASS for post-stroke 
problems. Therefore, little is known about their understanding and perceptions of 
symptoms after experiencing this potentially life-threatening event. Research has 
indicated that despite the absence of neurological deficits at discharge, this population 
describes experiencing unexpected and invisible symptoms that can be categorized as 
depressive symptoms and cognitive deficits including executive dysfunction (Sobreiro et 
al., 2014). In general, depressive symptoms are common post stroke; one-third of stroke 
patients develop depression (Hackett & Pickles, 2014). 
Prior to hospital discharge following stroke, there are requirements for patients to 
receive stroke education. However, the required stroke education elements based upon 
the standards for the four levels of Joint Commission Stroke Center certification do not 
include information about ongoing effects of stroke, but rather focus on risk factors, 
when to call 911 and the signs and symptoms of acute stroke (Specifications Manual, 
2018). Only hospitals that are certified as comprehensive stroke centers are directed to 
address cognitive deficits or depressive symptoms, and as of 2012 it became a 
requirement for comprehensive stroke centers to screen for depression in stroke patients 
(Facts about Comprehensive Stroke Center Certification, 2015). Education for this 
emerging population of YASS may be inadequate to address their unique needs, 
including potential symptoms post-stroke. 
In general, the best way to screen for depression and cognitive changes, and the 
optimal time when these screenings should occur in stroke survivors is unclear to 
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clinicians.  Stroke survivors with physical and mental disabilities require rehabilitation, 
and transition to acute inpatient rehabilitation units or centers. Most rehabilitation centers 
have robust opportunities for emotional and social support, and treatment for depression, 
fatigue and anxiety. YASS who discharge directly home are without those opportunities 
(Sadler et al., 2014). Symptoms that may include depression, cognitive changes, fatigue, 
and anxiety can affect the quality of life, productivity, and ultimately a successful 
transition back into the community for this population of YASS. 
Significance and Purpose 
There is a growing population of young adults having strokes, a wider acceptance 
and availability of technological advances and an expanding time window in 
interventional treatment for acute stroke, which will lead to more YASS who discharge 
directly home because of minimal to no neurological deficits. However, no studies have 
examined the psychosocial experiences these YASS have once they discharge home and 
whether these experiences are associated with quality of life.  
In preparation for home-going, nurses in the acute setting hold the primary 
responsibility of providing initial, ongoing and discharge education and require 
information and guidance for this teaching. Several meta-analyses have been published 
that address the 90 day to two year post-acute intervention periods in patients of all ages 
treated for large vessel ischemic stroke, but the primary focus of these meta-analyses 
have been functional outcomes and mortality (Mistry et al., 2017; Vidale & Agostoni, 
2017; van den Berg et al., 2017). Quality of life and the presence of fatigue, anxiety and 
depressive symptoms have not been independently investigated in patients treated with 
thrombectomy for large vessel ischemic stroke. Unmet psychosocial and cognitive needs 
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may impede reentry into the workforce, parenting, caring for aging parents and 
relationships with partners. While other YASS studies focus on physical limitations, 
changes in self-perception, and mild stroke, for those with few to no neurological initially 
apparent deficits after large stroke, there are unexplored areas, which require future 
investigation. Compared to YASS who do have deficits requiring inpatient rehabilitation, 
YASS with acute reversal of symptoms may have different needs post hospital discharge 
that are still related to the acute event. 
This study aimed to describe how a sample of YASS ages 18-55 years, who 
underwent thrombectomy and discharged directly home from the hospital, understand 
and perceive their post-stroke symptoms, as well as describe the objective presence or 
absence of those symptoms. A quantitative assessment of the YASS perceptions and 
beliefs about their symptoms was explored using standard measures for anxiety, fatigue, 
depressive symptoms, and stroke specific quality of life. The assessment was guided by 
the Common-Sense Model of Self-Regulation which posits that addressing perceptions 
about individuals’ symptoms and diagnosis may assist recovery through early 
interventions including education and structures for framing individuals’ experiences and 
seeking care (Leventhal, Phillips, & Burns, 2016). Understanding YASS new or ongoing 
symptoms and how they interpret these symptoms may help with perception of stroke 
specific health related quality of life, normalization, recognition and utilization of 
resources, and help to mitigate the negative impact these symptoms have on recovery. 
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Research Questions 
In a sample of YASS ages 18-55 years with first ever ischemic stroke, who received 
intravenous alteplase and/or mechanical thrombectomy, had minimal physical deficits (a 
score of 0-3 on the modified Rankin Scale) and discharged directly home from the 
hospital, using the Common Sense Model: 
1) What are the most common symptoms reported by YASS, between one and 
eighteen months post-stroke?  
2) What are the relationships among clinical variables (NIHSS, mRS), anxiety, 
fatigue, depressive symptoms and stroke specific quality of life, in YASS? 
3) What do YASS report are the identity, timeline, causes, consequences and 
control of post-stroke symptoms of anxiety, fatigue and depression between one 
and eighteen months post-discharge?  
Specific Aims 
1) To describe YASS post-stroke symptoms and how they understand 
and perceive their post-stroke symptoms using the Common Sense Model. 
2) To examine bivariate relationships between post-stroke symptoms (anxiety,  
fatigue, depression, threatening illness perception) and stroke specific quality of  
life. 
Hypotheses 
1) Levels of anxiety, fatigue and depression will be elevated in YASS. 
2) Higher levels of anxiety, fatigue, depression, threatening illness perception 
will be associated with lower stroke specific quality of life. 
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Applying the Common-Sense Model in YASS 
This study was guided by the components of Leventhal’s Common-Sense Model 
(CSM) of Self Regulation (Leventhal, Philips & Burns, 2016). This model is typically 
used to examine how individuals interpret, perceive and respond to their illnesses. Use of 
the model assists clinicians in understanding how patients’ illness representations may 
predict patients’ response to illness, and to potentially develop interventions to help with 
more favorable outcomes (Hale, Treharne, & Kitas, 2007). The components of this model 
may be associated with the processes by which YASS perceive, define, and respond to 
their acute stroke in the post-discharge environment. Although the acute threat of 
physically disabling disease may have passed post-discharge, this study seeks to examine 
in the context of this model how it applies to the ongoing self-management of what 
symptoms come to represent ongoing health threats.  
The model is applicable to acute or chronic conditions, and for this study the 
concepts of interest are defined as acute, as perceived physical or cognitive symptoms 
(Leventhal et al., 2016). The World Health Organization (WHO) defines acute stroke as a 
sudden occurrence of general brain impairment or focal neurological deficits, where 
symptoms persist greater than 24 hours and are definitively caused by a vascular event 
(World Health Organization, 2017). While ultimately YASS may have their symptoms 
reversed through intervention before the 24-hour period, the sudden onset and severity of 
the symptoms attributed to vascular disruption are defined here as acute. Symptoms to be 
explored in this context include anxiety, fatigue, depressive symptoms, and stroke 
specific quality of life. 
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Overview and Concepts 
 The CSM of Self-Regulation describes a dynamic process by which individuals 
recognize deviations from their normal functional selves through various stimuli, which 
may include physical symptoms, perceived changes, medical diagnoses, discussions with 
other individuals, social or mass media, and environmental cues (Leventhal, Phillips, & 
Burns, 2016). This input activates a mental representation of an individual’s normal self, 
combining previous experiences with illness, how illness was or should be managed and 
ultimately of what constitutes an illness threat. These representations are derived through 
parallel emotional or subjective feelings and cognitive beliefs (Leventhal, Phillips & 
Burns, 2016). The cognitive beliefs are developed through five core constructs or 
components that include identity, time-line, consequences, causes and control (Leventhal, 
Leventhal & Breland, 2011). If these perceptions are understood by healthcare providers, 
they may help to guide mechanisms for identifying YASS at risk for experiencing 
anxiety, fatigue, and depressive symptoms, and managing their treatment or recovery. 
 There is a dual process by which each of the five constructs is both perceptual and 
simultaneously representative of possible actions for self-management and/or treatments 
(Leventhal, Leventhal, & Breland, 2011). The five core constructs as interpreted in the 
context of these YASS are described here.  
Identity is the attribution of the symptom or experience to an event such as stroke, 
as well as the perceived severity of the threat (Leventhal, Philips, & Burns, 2016). 
Examples of the symptoms that may be labeled by the patient include “anxiety” or 
“fatigue”. Severity may apply to the ability of the symptom to interfere with functional 
recovery. 
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Time-line construct is the patient’s understanding of the timing of and the rate at 
which the symptoms started, how long he/she experiences them and their decline, if 
applicable (Leventhal, Philips, & Burns, 2016). For example, depressive symptoms may 
be viewed as short term and something that will resolve in time. Here the individual also 
develops a representation of how long treatment may occur and expectations of when 
benefits would be observed. 
Consequences of symptoms describes both those experienced as well as those 
identified as possible, by the patient, and whether they are perceived as serious or not. 
These can be physical, cognitive, or psychosocial (Leventhal, Phillips, & Burns, 2016). 
For example, after their acute stroke resolves by receiving thrombectomy, some YASS 
have reported feeling a disconnect, a slowness of thoughts or not feeling like themselves 
(Seagraves, 2017). 
Determinants or causes explain to what the patient, who has experienced reversal 
of a large stroke, attributes the current symptoms or sensations (Leventhal, Phillips, & 
Burns, 2016). For example, YASS may or may not recognize that the symptoms 
experienced are potentially ongoing physiological consequences of the acute stroke. 
Control is the fifth and final contributor to understanding the health threat. This 
refers to the patient experiences, or the belief of whether the experiences, which are a 
variation from the normal self, will or do respond to self-management (Leventhal, 
Phillips, & Burns, 2016). Perceptions of potential benefits of treatment are also 
considered under this domain. According to the CSM, the YASS’ perceptions, as 
determined by their representations from the five constructs, may contribute to their 
motivation to seek care and to how they cope with their recovery. 
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Figure 1.  Adaptation of the Common Sense Model in YASS  
Anxiety is a concept included in the model. Merriam Webster’s Online Dictionary 
(2018) describes the medical definition of anxiety as “an abnormal and overwhelming 
sense of apprehension and fear often marked by physical signs (such as tension, sweating, 
and increased pulse rate), by doubt concerning the reality and nature of the threat, and by 
self-doubt about one's capacity to cope with it”. The presence and levels of anxiety in 
YASS in the study were measured using the Hospital Anxiety and Depression Scale 
(HADS) (Zigmond & Snaith, 1983). Participants may not identify their symptoms as 
signs of anxiety as defined in the selected instrument. 
 Depressive Symptoms is a concept included in the model. Merriam Webster’s 
Online Dictionary (2018) describes the medical condition of depression as inclusive of 
the following depressive symptoms: “sadness, inactivity, difficulty in thinking and 
concentration, a significant increase or decrease in appetite and time spent sleeping, 
feelings of dejection and hopelessness, and sometimes suicidal tendencies”. The presence 
and levels of depressive symptoms in YASS in the study were measured using the HADS 
(Zigmond & Snaith, 1983). The instrument is designed to identify symptoms, not a 
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comprehensive tool for diagnosing depression. Participants may not identify their 
symptoms as related to depressive symptoms as defined in the selected instrument. 
 Fatigue is a concept that is included in the model. Merriam Webster’s Online 
Dictionary (2018) describes the medical definition of fatigue as “weariness or exhaustion 
from labor, exertion, or stress”. Generally, fatigue is defined as the state of being very 
tired or as weariness. The presence and levels of fatigue in YASS in the study were 
measured using the Fatigue Severity Scale (FSS) (Krupp et al., 1989). 
Quality of life is a concept included in the model as the study examined the 
possible relationships among anxiety, fatigue, depressive symptoms, and stroke specific 
quality of life. There were twelve domains that were reflected in one of the selected 
instruments for this study that in survivors of mild to moderate stroke, through self-
reported experiences, may impact the YASS’ quality of life (Williams et al., 1999). The 
constructs examined include mobility, energy, upper extremity function, 
work/productivity, mood, self-care, social roles, family roles, vision, language, thinking 
and personality. The individual sense of well being in the YASS may be related to 
anxiety, fatigue, depressive symptoms, and illness perception as they process them 
through the five core constructs, and in parallel through emotional/subjective 
representations. 
Application of the Common-Sense Model 
The application of the CSM has expanded over time. Leventhal, Leventhal & 
Breland (2010) recognized that the CSM had been used widely in the study of cognitive 
function using objective measures but would benefit from the study of the CSM in 
examining individuals’ perceptions of their cognitive function and the positive or 
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negative impact on their recovery, therefore using subjective measures. The CSM has 
more recently been used by researchers to study individuals with mild traumatic brain 
injury (MTBI) in the context of their injury beliefs, coping, recovery and outcomes 
(Snell, Hay-Smith, Surgenor, & Siegert, 2013). Their study demonstrated that the 
components of identity, time-line, consequences, and emotional representations of their 
MTBI were associated with reduced functional difficulties over time and that these 
patients may benefit from early interventions to change perceptions, specifically related 
to setting realistic expectations for recovery time. A study seeking to reduce post-partum 
depressive symptoms in African-American and Hispanic women used the CSM as a basis 
for an intervention aimed at influencing the five core constructs used to develop their 
expectations of the postpartum self (Howell, Bodnar-Deren, Balbierz, Loudon, Mora, 
Zlotnik, Wang, & Leventhal, 2013). This intervention guided the women’s                                                                                                                                             
expectations to a realistic representation that subsequently matched the actual feelings 
and function experienced by the participants, resulting in a 40% reduction of depressive 
symptoms. 
 Using the CSM of Self-Regulation may help with predicting and interpreting the 
presence or absence of alignment between YASS expectations, experiences, and 
physiological manifestations post-acute stroke. In order to facilitate use of the CSM, the 
Illness Perceptions Questionnaire (IPQ) was developed to assess individual patients’ 
illness representations (Weinman, Petrie, Moss-Morris, & Horne, 1996). The Revised 
Illness Perceptions Questionnaire (IPQ-R) includes an emotional representation sub-
scale, additional symptom coherence items, and additional attributional items in the 
causal section (Moss-Morris et al., 2002). This quantitative instrument can be modified to 
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ask specific questions on the identity and causal scales regarding beliefs about the 
symptoms experienced by YASS. These perceived threats and responses on an 
abbreviated version of the instrument associated with the theory, the Brief IPQ, were 
compared to clinical levels, as reported on standard questionnaires of anxiety, depressive 
symptoms, fatigue, and stroke specific quality of life. The authors of both the original and 
revised scales encourage adapting the scales to the individual population of interest, in 
this case the YASS who have had a reversal of the devastating physical deficits of acute 
stroke, as there may be an association between the way in which an illness, event or 
symptom is perceived and the outcomes related to recovery and transition back to their 
normal state of health. The constructs may be perceived individually but may be 
interrelated. For example, a YASS may be experiencing anxiety which may impact the 
ability to sleep, which could contribute to fatigue. Depressive symptoms may inhibit 
motivation to participate in social activities, which may impact quality of life. 
 
 
14 
 
CHAPTER II  
REVIEW OF LITERATURE 
Background 
This chapter provides a review of recent literature of what is known about the 
consequences of stroke in YASS. The different topics explored include common 
problems following stroke, such as depressive symptoms, fatigue, and anxiety. Next, 
qualitative and quantitative studies of symptoms of YASS, including potential symptoms 
impacting return to work in stroke survivors will be described. Additional literature is 
examined regarding problems in survivors of minor stroke, including the relationship of 
symptoms to quality of life. 
The body of knowledge surrounding the consequences of stroke is expansive. 
Vast data bases such as the American Heart Association’s Get with the Guidelines 
(GWTG) capture pre-hospital to post-acute care outcomes including stroke severity and 
level of ongoing disability for stroke survivors (American Heart Association, 2016). The 
Centers for Disease Control and Prevention (CDC) report the financial burden of stroke 
in the United States as $34 billion annually, which includes the cost of health care, 
medications, and lost wages (CDC, 2016). Stroke in the young causes a disproportionate 
share of the cost as these individuals are working age and in their productive years 
(Smajlovic, 2015). Physical disabilities following stroke often impede return to work, 
however, psychosocial factors can also influence return to work and possibly affect 
quality and duration of work.  
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Qualitative Studies of the Experiences of Young Adult Stroke Survivors 
 Qualitative analyses have captured and categorized the experiences of stroke 
survivors across the full spectrum of disability and age (Kuluski, Dow, Locock, Lyons, & 
Lasserson, 2014; Lawrence & Kinn, 2012; Martinsen, Kirkevold, & Sveen, 2012; Sadler, 
Daniel, Wolfe, & McKevitt, 2014). The studies with participants considered young 
included those ages18-62, who ranged from 1.5 months to 12 years post-stroke, with 
varying types of strokes, treatments, and disabilities. The subjective experiences of stroke 
survivors helped to frame the quantitative design by guiding the researcher’s selection of 
concepts and instruments to measure the identified symptoms. 
Kuluski et al. (2014) sought to understand experiences of stroke as disabling to 
life in their interviews with 17 YASS ≤55 years of age, who were between 1-12 years 
post stroke. Using directed content analysis, they found that all 17 YASS experienced at 
least one symptom including fatigue, speech and memory impairment, physiological 
symptoms and challenges with multi-tasking, from which emerged two main themes of 
“altered sense of self” and a “loss of identity”. All of the survivors attributed their 
symptoms to their stroke. Similarly, Lawrence & Kinn (2012) interviewed 10 YASS age 
18-55 who were three months to two years post stroke. One of their subthemes was 
“embodied perception of difference”, which included fatigue, impaired memory, poor 
concentration, vision problems and impaired decision-making skills. These survivors 
indicated that the cognitive impairments post-stroke were not noticeable when they were 
in their home environments but came to light upon return to work. A third group of 22 
YASS, ages 20-61, were interviewed to determine the impact of stroke, 6-9 months post-
stroke, on family life (Martinsen, Kirkevold & Sveen, 2012). The YASS identified 
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parenting challenges related to memory loss, slow thinking and absent-mindedness and a 
struggle to reintegrate and fulfill the parenting role. Lastly, in their investigation of YASS 
navigating the field of stroke care in the United Kingdom, Sadler et al. (2014), 
interviewed 31 survivors, ages 24-62 years of age between six weeks and 28 months post 
stroke. Two thirds of those interviewed indicated they were still looking for support with 
social, psychological and emotional issues. They indicated a need for guidance toward 
financial resources and emotional support systems, as they felt isolated and had 
challenges coping. A sub-group of five women in the study, with self-reported anxiety 
and depression before their stroke, expressed emotional challenges coping with stroke, 
including symptoms of crying, mood swings, and depression. 
The body of qualitative evidence of post-stroke symptoms in YASS includes a 
variety of psychosocial symptoms including fatigue and cognitive changes, and points to 
a need for further study of the reported symptoms. The identified symptoms appear to 
affect quality of life, returning to work, relationships and parenting. However, these 
studies may not include the YASS population of interest, therefore it is important to see if 
they experience the same or similar things. The use of quantitative designs with standard 
measures may be useful to characterize the level of symptoms and whether the symptoms 
are at clinically important levels. 
Quantitative Studies of Symptoms in Young Adult Stroke Survivors 
Descriptive studies of YASS are widely available and there is evidence of 
common sequela of stroke such as the presence of depressive symptoms, fatigue, anxiety 
and challenges returning to work, executive dysfunction, and memory problems (Glozier, 
Hackett, Parag, & Anderson, 2008; Maaijwee et al., 2014; Naess & Nyland, 2013; 
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Sobreiro et al., 2014; Waje-Andreassen, Thomassen, Jususfovic, Power, Eide, Vedeler, & 
Naess, 2013; Wang, Kapellusch, & Gaeg, 2012).  The following studies describe the 
prevalence of post-stroke symptoms experienced by YASS, and with YASS being of 
working age, most of the studies also describe the impact of these symptoms on their 
ability to effectively return to work.  
Naess & Nyland (2013) examined post stroke fatigue and depression and their 
role in mortality in a sample of 190 YASS in Norway, ages 15-50 (M=48, SD=9.3). In 
this prospective cohort study, the modified Rankin Scale (mRS) was used to assess 
physical function, fatigue was evaluated using the Fatigue Severity Scale (FSS) and 
depression was assessed using the Montgomery-Asberg Depression Rating Scale 
(MADRS). Stroke survivors were followed for 12 years, the mean mRS was 1.3, SD=1.0, 
indicating no symptoms or significant disability, but fatigue and depression were 
associated with long-term mortality, irrespective of stroke severity.  In another study 
conducted in Norway, Waje-Andreassen et al. (2013) assessed memory, anxiety, 
depression and sleep in a group of 144 YASS age ≤49 years and compared their 
symptoms to 167 matched controls, comprised of normal adults matched retrospectively 
for age and sex. Their study represented population- based long term follow up at 12 
years from onset of stroke and aimed to investigate the above concepts in relation to 
functional outcome and full-time work. Like Naess & Nyland (2013) they also used the 
mRS to assess function, considering a 0-1 as an excellent outcome. Nearly 71% of YASS 
(102/144) had a mRS of 0-1. YASS also completed a questionnaire with yes/no responses 
about memory problems, anxiety, depression, sleeping problems, and work. As compared 
to 5.4% of controls, 41% of YASS had memory problems. Of those YASS with memory 
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problems, only 20.3% worked full time. In YASS versus controls, anxiety was 19% 
compared to 9%, depression was 29% compared to13%, and sleeping problems which 
can be associated with fatigue was 36% compared to 19% in controls.  
Whether a stroke survivor returns to work may be explained by the symptoms 
they experience post-stroke. The next three studies describe factors inhibiting return to 
work among stroke survivors. Glozier et al. (2008) examined a component of the third 
Auckland Regional Community Stroke (ARCOS) study to determine contributors to and 
frequency of stroke survivors ages ≥15 years old return to paid work. This prospective 
population-based study included baseline interviews with 1423 stroke survivors between 
2002-2003, of which 279 (20%) were involved in paid employment at the time of the 
stroke, were experiencing their first ever stroke and were cognitively competent to 
answer questions independent of a proxy. The Barthel Index (BI) was assessed at one-
week post-stroke as a measure of functional dependence or independence. From this 
population, 55 did not survive into the follow-up period. Follow-up telephone interviews 
were conducted with the 224 surviving patients, with a mean age of 55 (SD=11), with 
169 of the participants completing the General Health Questionnaire (GHQ-28) to assess 
psychiatric morbidity, at one and six months after the initial event. The BI scores of those 
completing the GHQ-28 were higher than those who did not complete the questionnaire 
(M=17, SD=5 versus M=13, SD=8). Psychiatric morbidity, also commonly referred to as 
depressive symptoms, was present in 43% of those who were working at six months 
compared with 64% in those not working at six months. Thus, the likelihood of returning 
to paid work was reduced in the presence of early psychiatric morbidity (OR 0.42; 95% 
CI 0.22 to 0.80, p value 0.008).  
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In another study examining return to paid work, Andersen et al. (2012) explored 
the relationship of fatigue with returning to paid work in a group of 83 first-ever stroke 
survivors aged ˂60 years, who were employed full or part time at baseline. Patients were 
recruited between 2003-2005 from Arhaus University Hospital in Denmark and were 
followed for two years from the onset of stroke. Interviews were conducted with the 
stroke survivors at 10 days, three months, one year, and two years after stroke. 
Sociodemographic data collected including sex, age and employment status.  The Barthel 
Index (BI) was used to assess physical function, the Symbol Digits Modalities Test 
(SDMT) was used to assess cognitive function, and the Major Depression Inventory 
(MDI) was used to assess new onset depression and antidepressant treatment. Fatigue 
was the focus of the study thus patients completed a self-rating on the Multidimensional 
Fatigue Inventory (MFI-20), which contains four dimensions and a maximum score of 
20. A score of ≥12/20 in the dimension of general fatigue was used as the cutoff for 
clinically significant pathological fatigue. The percentage of stroke survivors who had 
returned to work at least part-time (10 hours minimum) or full-time were 53% at year one 
and 58% at year two. Multivariate regression analysis identified fatigue as a strong 
predictor of the stroke survivors’ chances of returning to paid work. At baseline, the 
adjusted odds ratio (OR) for return to paid work was 0.39 (95% CI 0.16-1.08) for those 
with a general fatigue score of ≥12 indicating significant levels of fatigue. At two years 
those who still had significant fatigue (≥12) had an OR of 0.29 (95% CI 0.11-0.74). 
These results were independent of cognitive deficits and physical disability. 
In a comprehensive review of the literature, Wang, Kapellusch, & Gaeg (2012) 
examined the results of 42 studies, primarily quantitative, to summarize the factors that 
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have been found to influence whether stroke survivors return to work. One of the studies 
they included (Wolf, Baum, & Connor, 2009) examined registry data from 7,740 stroke 
patients from a single hospital in the United States from 1999-Spring 2008, and found 
that 45% of stroke patients were under age 65, and 27% were under age 55, falling into 
the working age bracket. Wang, Kapellusch, & Gaeg divided the predictors of return to 
paid work from the 42 included studies into 6 categories, which were demographic 
variables, body structures, body functions, activity and participation, psychosocial and 
other personal factors, environmental factors, and job factors. The body functions 
category included subtle cognitive defects, which were only found to be described 
qualitatively and thus not statistically examined. These defects included impairment in 
multi-tasking, concentration, working memory, mental speed and flexibility, and visual-
spatial ability. Younger age, higher physical function, family support and white-collar 
work were strong predictors of returning to work. Depression was found in 48% of the 
individuals included across studies, as determined at stroke follow-up visits, not at the 
time of stroke, and was negatively associated with returning to work. 
 Executive dysfunction, defined as a disruption to the performance of a group of 
cognitive processes that regulate and control planning and following through with 
activities and goals, has been observed among YASS and examples are provided in the 
following studies. Maaijwee et al. (2014) extracted data from the Follow-Up of Transient 
ischemic attack and stroke patients and Unelucidated Risk factor Evaluation (FUTURE) 
study, which examined first ever stroke patients ages 18-50, admitted to one medical 
center in the Netherlands between 1980-2010. Their sample included 160 patients who 
had Transient Ischemic Attack (TIA) and 277 who experienced ischemic stroke. YASS 
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were matched with 146 stroke and TIA free controls on age. The purpose of this study 
was to investigate the long-term prevalence of subjective cognitive failures, and to 
investigate the relationship between subjective and cognitive failures and objective 
performance. All participants were invited to a follow-up exam in 2009-2010 where they 
completed a 15 item semi-structured interview based on the Cognitive Failure 
Questionnaire (CFQ), which focused on memory and executive function. Participants 
underwent thorough neuro-psychological testing for working memory using the Paper 
and Pencil Memory Scanning Test (PPMST), immediate and delayed memory using the 
Ray-Osterreith Complex Figure Test (ROCF) and Rey Auditory Verbal Learning Test 
(RAVLT). Executive function was tested using Verbal Fluency and Stroop Interference. 
The results, while not statistically significant, indicated that subjective memory failures 
were present in 86.4% of patients as compared to 67.4% in controls, and executive 
failures were found in 67.4% of patients as compared to 41.4% in controls. Conversely, 
the only statistically significant association between subjective and objective assessments 
was a weak association between subjects’ subjective cognitive failures and objective 
immediate and delayed memory performance. It is possible that YASS who receive 
mechanical thrombectomy with full resolution of symptoms may meet criteria as TIA 
survivors based on pristine neurological imaging post-procedure, if the stroke did not 
have time to cause permanent tissue damage. YASS memory and cognitive deficits need 
to be addressed by the health care professional, as they may require education, treatment 
and coping strategies.  
Depression-executive dysfunction was assessed by Sobreiro et al. (2014) in non-
elderly stroke patients by examining the association between the retardation domain of 
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depressive symptoms and performing poorly on executive function testing. They enrolled 
87 participants with a mean age of 50.7 (SD=14.5), with first ever MRI confirmed stroke 
and no pre-existing major depression. There was, however, no normal control group 
included in the study. Stroke survivors underwent neuro-psychological testing including 
the Wechsler Digit Span test, FAS-Spoken Verbal Fluency test, Victoria Stroop test, and 
depressive symptoms testing with the Hamilton Rating Scale for Depression (HAM-D-
31) within the 23-day period post stroke. Results indicated that there was an association 
between the fatigue/interest domain of HAM-D-31 with poor performance on the FAS 
and on the Stroop Interference (reaction time of a task) in those <60 years of age, which 
is consistent with existence of depression-executive dysfunction after stroke in younger 
stroke patients.  
These above studies describe the presence of a variety of post-stroke symptoms 
up to one year in YASS. The presence of actual or perceived physiological symptoms 
such as depression, fatigue, anxiety and executive dysfunction appear to impact their 
ability to return to paid work and mortality, independent of level of physical disability 
and may impact quality of life. These post-stroke complications have not been examined 
specifically in the YASS population of interest. These study results indicate a need for 
treatment for depression, anxiety, fatigue, cognitive therapy, neurorehabilitation and 
neurostimulation in YASS as this syndrome may impact social interaction and return to 
work. Long term ongoing challenges are present in previously studied populations of 
YASS with excellent functional outcomes, with worse prognosis for memory problems, 
anxiety, depression and capacity for full-time employment compared to controls. 
Opportunities may exist for early intervention for identification and management of 
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depressive symptoms, fatigue and anxiety to increase likelihood to return to paid work 
after stroke. 
Survivors of Mild Stroke 
The phenomenon of mild stroke has been thoroughly evaluated in adult stroke 
survivors but infrequently evaluated specifically in YASS. There is strong evidence of 
ongoing symptoms related to cognitive deficits, executive dysfunction, depressive 
symptoms, depression, anxiety and a significant impact on return to work in adults who 
have experienced mild stroke (Altieri et al., 2011; Broomfield, Quinn, Abdul-Rahim, 
Walters, & Evans, 2014; Corbetta et al., 2015; de Bruijn et al., 2015; Guajardo et al., 
2015; Hommel et al., 2009; Palmcrantz, Holmqvst, & Sommerfeld, 2014). There is no 
scientific consensus as to what defines mild stroke, however it has been defined in the 
above referenced studies as smaller infarct size, NIHSS ≤ 3-6, stroke not requiring 
intervention or admission to critical care, or by duration of symptoms and physical 
disability. Only two studies examining mild stroke had a sample of participants with a 
mean age <55 years (de Bruijn et al., 2015; Hommel et al., 2009). 
The first study by de Bruijn et al. (2015) examined what stroke-specific medical 
and psychological factors may impact the quality of life (QoL) of young ischemic stroke 
patients at > 1-year post-stroke. The 170 YASS and 61 non-stroke general controls <57 
years of age completed the shortened World Health Organization Quality of Life scale 
(WHOQOL-BREF 26), to assess quality of life, the Fatigue Assessment Scale (FAS), to 
assess physical and mental fatigue, and the Hospital Anxiety and Depression Scale 
(HADS), to assess for depressive symptoms and symptoms of anxiety. Follow-up 
telephone calls by investigators assessed the mRS and employment status of the YASS. 
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At a mean point of 4.5 years post-stroke, anxiety, depression and fatigue were present in 
YASS at 31.9%, 37.2%, and 57.8%, as compared to controls at 17.8%, 6.7%, and 15.9% 
respectively. Lower quality of life was associated with higher scores in anxiety, 
depression, and fatigue. 
In the second study taking place in France, Hommel et al. (2009) assessed social 
dysfunction and its contributing factors in 84 first-ever mild to moderate stroke survivors 
who were of vocational age, defined as 18-64 years old with a mean age of 43.5 
(SD=12.2). These stroke survivors were assessed between three and nine months post 
stroke (median 7 months) and had no apparent severe neurological deficits, with an 
NIHSS <4, mRS score ≤2 and an MMSE score of at least 23/30 to exclude dementia. 
Participants completed the Work and Social Adjustment Scale (WSAS), the HADS and 
MMSE (administered by a neuropsychologist), the BDI, and were asked about return to 
work at one year. A stroke neurologist ranked the level of disability as having no social 
dysfunction, mild to moderate social dysfunction, or severe social dysfunction. Physician 
rankings strongly correlated with patient’s self-reported WSAS results, confirming self-
perception of dysfunction was reflected in clinical assessments. The mean WSAS was 
16.1(SD=10) indicating significant social dysfunction and most participants (68%) 
reported a high level of work and social dysfunction that they attributed to their stroke. 
Despite the high levels of social dysfunction, survivors had low depression and anxiety 
scores and high mental exam scores. Depression results may have been confounded by 
the fact that 42% of participants were taking anti-depressants at the time of the analysis. 
While mean NIHSS on admission for stroke indicated a mild to moderate event at a mean 
of 5.8, the score was down to 0.9 in the NIHSS and mRS 1.4 at the time stroke survivors 
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completed the WSAS, indicating almost complete absence of physical or motor deficits. 
Indications are that initial stroke severity may have a greater impact on long term social 
dysfunction than presence of subsequent physical neurological impairments. 
In an older population of 105 survivors of mild stroke, Altieri et al. (2011) sought 
to determine the prevalence and predictors of depression over a 30-month time period, 
with mild defined as having an NIHSS of ≤5. Participants with a mean age of 64.38 were 
enrolled at one hospital in Italy. At one-month post-discharge participants underwent a 
standardized neuropsychological assessment for memory, attention, visuospatial function, 
executive function, conceptual thinking and language. The Beck Depression Inventory 
Short Form (BDI-SF) was used to assess depressive symptoms; however, it was only 
administered at the one-month post stroke period. Ongoing depression diagnoses were 
made based on the results of the Structured Clinical Interview for the DSM-IV results 
using DSM-IV criteria. These were repeated yearly and at 30 months. Forty percent of 
stroke survivors exhibited post-stroke depression by the end of the 30-month follow-up 
period, and half of these were depressed at the one-month period, with the most frequent 
depressive symptoms being work inhibition, indecisiveness, fatigue, sadness and crying. 
Broomfield et al. (2014) examined data from a community registry in Scotland for 
prevalence of anxiety and depression in a cohort of community dwelling minor stroke 
(N=4,079) and TIA survivors (N=1,247) using the HADS score. The median age of the 
stroke cohort was 70.3 (IQR=11.3), and the median age of the TIA cohort was 70.8 
(IQR=10.9). Investigators found that 29% of participants in both groups had probable 
anxiety, and 24% of those with mild stroke and 21% with TIA had scores indicative of 
depression. Similar levels of symptoms present between the two groups, those with stroke 
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and those with minor stroke or TIA, reflect a need for assessment and possible 
interventions for those with mild or reversed symptoms of stroke. 
Lastly, Palmcrantz, Holmqvst, & Sommerfeld (2014) examined long-term 
functioning and disability and perceived disability in a sample of 150 YASS aged 18-64 
years with all types of stroke, against a matched sample in the general population of 
Sweden of 2661 individuals free of stroke. Participants completed both the European 
Quality of Life- 5Dimensions (EQ-5D), a standardized measure of health, and the 
researcher-developed Mapping Young People with Stroke (MYS) questionnaires to 
assess self-rated disability between three months to six years post stroke. The level of 
stroke was defined as mild in 79% of YASS yet 45% rated their global health as low 
compared to 15% of controls. YASS ratings of their global health were lower for those 
who reported experiencing symptoms or the presence of perceived deficits in areas such 
as tiredness (45%), limits in leisure activities (57%), and work limitations (39%). 
Survivors of mild stroke may be the closes to the target population of YASS for 
this study. Similar to studies described earlier for survivors of more severe stroke, 
outcomes of mild stroke in the studies reviewed included significant levels of depression 
and depressive symptoms, anxiety, fatigue, social and work dysfunction and lower 
quality of life. The findings of the studies suggest that even survivors of mild stroke need 
to be educated, assessed and treated for these complications following stroke. 
Quality of Life Following Stroke 
Descriptive studies of adult stroke survivors have identified mood symptoms and 
psychological consequences of stroke. These common sequalae may impact quality of 
life in stroke survivors. For example, Donellan et al. (2010) examined how depression 
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and anxiety impact functional recovery and health-related quality of life (HRQoL) in 107 
stroke survivors from two hospitals in Ireland, at one-month post stroke and then repeated 
at one year. The instrument used to measure anxiety was the Hospital Anxiety and 
Depression Scale (HADS). They used the Nottingham Extended Activities of Daily 
Living scale (NEADL) to measure functional recovery and to measure HRQoL they 
administered the Stroke-Specific Quality of Life scale. Results indicated just over a third 
of stroke survivors experienced depressive symptoms and anxiety at one-month post 
stroke, and a third also experienced depressive symptoms and anxiety at one year. The 
third was not comprised of the same individuals at the two different time points. More 
depressive symptoms were associated with poorer functional ability. Higher depressive 
symptoms and presence of anxiety were both significantly associated with worse 
HRQoL. In a study by de Bruijn et al. (2015) described earlier, anxiety, depression and 
fatigue were significantly associated with poorer quality of life in a sample of young 
ischemic stroke survivors > one-year post stroke.  
The research on quality of life following stroke indicates that anxiety, depression 
and fatigue are culprits to lower quality of life.  Few studies have examined quality of life 
in YASS and none have examined quality of life among the YASS population of interest 
or the role symptoms play in explaining quality of life in this population. Identifying 
post-stroke symptoms that may be present among YASS is important for understanding 
their transition back to self, socialization, work and overall quality of life. 
Gaps in the Literature 
The body of work described above demonstrates a review of the evidence for the 
existence of mood disorders, cognitive deficits including executive dysfunction, 
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depressive symptoms, memory problems, fatigue, anxiety, social dysfunction and 
challenges returning to work in stroke and TIA survivors, including separate cohorts of 
all adult stroke ages and stroke severity, YASS with varying stroke severity and stroke 
survivors with mild severity. Limitations include the wide variety of inclusion criteria, 
age ranges, study designs including follow-up periods, and instruments used to assess 
similar phenomena. Many of the studies were conducted outside of the United States thus 
findings may not be generalizable to YASS in the United States. None of the studies 
included or differentiated participation of minority or vulnerable populations. Most 
studies included at minimum the type of stroke and demographic characteristics of the 
participants. Severity of stroke was often categorized, but one striking differentiation was 
missing in all but one of the studies: the presenting level of deficit in contrast to the level 
of neurological dysfunction upon discharge from the acute setting. 
The phenomenon of interest for this proposal considers the YASS with large stroke upon 
presentation who subsequently, through intervention albeit medication or mechanical, has 
a reversal or major reduction in neurological symptoms. The current literature does not 
differentiate these YASS from all other stroke survivors. This emergent population of 
individuals benefiting from reversal of large stroke requires investigation to describe the 
prevalence of symptoms, their understanding and perceptions of the symptoms, whether 
the symptoms relate to health-related quality of life, as well as the measurable 
consequences, trajectory of and implications for functional, psychosocial and cognitive 
recovery. The study offered an opportunity to explore symptoms in YASS who represent 
varying racial and socioeconomic backgrounds. 
 
 
29 
 
CHAPTER III  
METHODS 
Design 
 This study used a cross-sectional, exploratory design. This non-experimental 
approach was selected to facilitate the aims of the study, which were to describe how 
YASS recognize, interpret, respond to, and attribute post-stroke symptoms, and to 
describe and objectively quantify the presence or absence of anxiety, fatigue, and 
depressive symptoms. Relationships among these variables and their relationship to 
stroke-specific quality of life were examined. Online surveys using Qualtrics and mailed 
paper surveys of the questionnaires were used. 
Setting 
 The study was conducted in the neuroscience department of a large, public, 
academic, safety-net hospital in metropolitan Atlanta, Georgia. The patient population of 
this hospital is racially diverse however the majority are African American. The patients 
are predominantly low income or unfunded. The 900-bed hospital serves acute stroke 
patients in a >150 mile catchment area, receiving emergent transfers for stroke treatment 
from nearly 70 hospitals, in urban, suburban and rural regions. In 2016, this hospital 
treated nearly1200 stroke patients, including 395 patients in the18-55 age range. In 2016, 
providers at this hospital performed the highest number of mechanical thrombectomy 
procedures for acute stroke of any single hospital in the United States, with 70 of those 
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being performed in patients between the ages of 18-55. These patients are seen in the 
clinic for follow-up visits after being discharged home from the stroke center, typically 
between 1-3 months post-acute stroke. The participants for the study were former 
inpatients who were treated in the hospital’s Stroke and Neuroscience Center, which is a 
Joint Commission Certified Advanced Comprehensive Stroke Center. 
Sample 
 The target population was young adult stroke survivors (YASS). All patients 
treated at the hospital meeting the inclusion criteria were invited to participate. The 
inclusion criteria were: 1) ages 18-55 years, 2) received mechanical thrombectomy 
treatment for first-ever ischemic stroke, 3) between 1-18 months post-acute stroke at the 
time of participation, 4) had a modified Rankin Scale (mRS) score of 0-3 (0-2 indicates 
functional independence but clinical documentation was used to determine independence 
in conjunction with the documented scale score at discharge) and had been discharged 
directly to home from the acute inpatient stay, 5) able to speak and read English, 6) 
willing to complete self-administered surveys, and 7) had access to a computer or smart 
phone or was willing and able to complete paper surveys by mail or in person at the 
hospital. The exclusion criteria were: 1) a history of psychiatric illness such as 
schizophrenia or other major depressive disorder, and 2) other major chronic co-
morbidity such as congestive heart failure, sickle cell disease, advanced (Stage IV) 
cancer. 
Sample Size 
 A review was conducted of all patients who received mechanical thrombectomy 
in 2016 to determine the available sample and sample size needed to identify the level of 
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anxiety, fatigue, depressive symptoms, and SS-QOL, as well as the identity, timeline, 
causes, consequences and control of post-stroke symptoms. The review indicated that 
57% (N=40) of the YASS discharged directly home after thrombectomy. In 2017 the 
annualized trend indicated a similar volume. Therefore, a reasonable number of 
participants was determined to be 30 for this pilot study. 
Instruments 
 Data were collected from the medical record and from four self-report instruments 
completed by the participants online using the Qualtrics application or on paper. 
Demographic and clinical characteristics of the sample were obtained from the medical 
record (Appendix A). The variables were age, sex and race; date, type and location of 
stroke; treatment modality (intravenous alteplase and/or mechanical thrombectomy); 
National Institutes of Health Stroke Scale (NIHSS) score on arrival to the hospital and at 
discharge home; and pre-morbid and discharge modified Rankin Scale (mRS) score, two 
valid and reliable frequently used measures of stroke disability. The NIHSS is a 15-item 
scale that measures stroke-related neurological deficits with scores ranging from 0-42, 
where 0 indicates no neurological deficits, ≤6 indicates chances for good recovery and 
≥16 indicates severe stroke (Adams, et al., 1999). The mRS measures physical disability 
and ranges from 0-6, where 0 indicates no symptoms, 1-5 indicates levels of disability 
ranging from no significant disability to severe disability, and 6 indicates death (van 
Sweiten, Koudstaal, Visser, Schouten, & van Gijn, J., 1988). Only YASS with discharge 
mRS of 0-3 were eligible to participate in the study.  
Two additional multiple-choice questions were added by the researcher to assess 
participant years of education attained and return to work or student status. Two open-
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ended questions were also included; the first requesting a telephone number should the 
student PI need to contact a participant about a questionnaire response, and the second 
offering an opportunity for participants to share anything else they would like the 
researchers to know about their stroke experience. Existing instruments were used to 
measure anxiety, fatigue, quality of life and illness perception via the Hospital Anxiety 
and Depression Scale (HADS), the Fatigue Severity Scale (FSS), the Stroke Specific 
Quality of Life (SS-QOL) scale, and the Brief Illness Perception Questionnaire (Brief 
IPQ) respectively. 
Anxiety and Depression 
 Anxiety and depression were measured using the Hospital Anxiety and 
Depression Scale (HADS) (Zigmond & Snaith, 1983) [Appendix B]. The HADS is a 14-
item tool, divided into two sub-scales, that is used to assess anxiety (7 items) and 
depression (7 items). It is a self-report scale for use in non-psychiatric individuals and 
requires participant responses to be based on frequency of symptoms over the previous 
week. The instrument can be completed in five minutes, and responses are on a 4-point 
Likert scale ranging from 0 “not at all”-3 “very often indeed” based on the frequency of 
occurrence. Sub-scale totals range from 0-21 and are reported separately for anxiety and 
depression. Items are summed and scores of 0-7 are considered normal, 8-10 are 
considered borderline abnormal, and 11-21 are abnormal. These ranges were validated in 
a general outpatient population sample-(N=50), aged 16-65 years, for anxiety with a cut-
off of 8: specificity=0.78, sensitivity=0.90 and for depression with a cut-off of 8: 
specificity=0.79, sensitivity=.083 (Zigmond & Snaith, 1983). Woolrich, Kennedy, & 
Tasiemski (2006) evaluated the HADS in a sample of 963 community dwelling 
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individuals in the United Kingdom, with varying levels of spinal cord injury. Their mean 
age was 48.1 years (SD=12.7; range 20–97) and 81% of the sample were male. The mean 
age at the time of injury was 28.6 years (SD=9.2; range 18–50) and the mean time since 
injury was 19.5 years (SD=12.26; range 2–56). Researchers performed a factor analysis 
and found a two-factor solution approximating anxiety and depression. Internal 
consistency was evaluated and for the anxiety sub-scale, the Cronbach’s alpha was .85, 
and for the depression sub-scale, the Cronbach’s alpha was .79 (Woolrich, Kennedy, & 
Tasiemski, 2006). A literature review of 747 published papers using HADS (Bjelland, 
Dahl, Haug & Neckelmann, 2002) demonstrated HADS was effective in assessing 
symptom severity and caseness of anxiety disorders and depression in a wide variety of 
clinical conditions, and in the general population. 
Fatigue 
 Fatigue was measured using the Fatigue Severity Scale (FSS) (Krupp et al., 1989) 
[Appendix C]. The FSS is a self-reported questionnaire used to assess the level of 
debilitating fatigue impacting function in all individuals, but more specifically was 
developed for and has been validated in a number of neurological disorders. The 
instrument contains nine questions, with responses on a 7-point Likert scale that ranges 
from 1 “strongly disagree” to 7 “strongly agree” (Krupp et al., 1989). Lower scores 
indicate lower fatigue severity. The questions are designed to be answered by participants 
based on frequency of symptoms over the previous week. The FSS can be scored 
obtaining a sum or an average of the items. In the early use of the FSS items were 
summed with total scores ranging from 9-63. A score of >36 was considered to be severe 
fatigue and indicated a need for further evaluation (Krupp et al., 1989). However, a recent 
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review of the literature revealed a more frequent use of calculating scores to obtain an 
average score (i.e. dividing the summed score by 9) ranging from 1-7 where a score of ≥4 
indicates severe fatigue (Learmonth et al., 2013). The latter method was used in the 
study. 
In a sample of Multiple Sclerosis (MS) patients (N=82), test-retest reliability of 
the FSS at six months (moderate at 0.75), precision (0.7, mean=5.1 points meaning a 
change of ˂0.7 points may be due to error), and clinically meaningful change (change in 
1.9 points on mean score necessary to reflect change) were demonstrated. Construct 
validity of the FSS was established with the Modified Fatigue Impact Scale (MFIS), with 
a Spearman correlation >.05 indicating a moderate relationship amongst all variables 
(Learmonth et al., 2013). Reliability and validity were also established in a sample of 
persons with spinal cord injury. For reliability the Cronbach’s alpha was .89 and the test-
retest Interclass Correlation Coefficient was .84, indicating adequate reliability. Construct 
validity was established (Pearson correlation r=0.67) with the Visual Analog Scale for 
Fatigue (VAS-F) and (r=0.58) the Center for Epidemiologic Studies Depression Scale 
(CES-D) (Anton, Miller, & Townson, 2008) indicating the FSS performed as 
hypothesized in direction and magnitude. The FSS also has been validated in a sample of 
individuals following stroke, helping to establish the utility of the scale in capturing the 
phenomenon of interest in the post-stroke patient population. When stroke patients 
(n=257) were matched with healthy individuals and measured at three months post-stroke 
using the FSS with a cutoff score of ≥4, stroke patients were found to have fatigue 
severity (above the cutoff score) prevalence of 31.1% as compared to the matched group 
prevalence rate of 10.9%. Participants also completed the fatigue question of the 
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HUNT3-survey and had similar results, indicating criterion validity of the FSS (Egerton 
et al., 2015). Overall the FSS has been established as a reliable and valid tool to measure 
the severity of fatigue. 
Health Related Quality of Life 
 Health related quality of life is a multidimensional construct and was measured by 
the Stroke Specific Quality of Life (SS-QOL) scale (Williams et al., 1999) [Appendix D]. 
The SS-QOL scale is 49-item questionnaire that is comprised of 12 domains, and divided 
into sub-scales which include energy, upper extremity function, work/productivity, mood, 
self-care, social roles, family roles, vision, language, thinking, and personality (Williams, 
et al., 1999). The questions are designed to be answered by participants based on their 
experiences over the previous week. The items are scored on a 5-point Likert scale, 
ranging from 1 = “strongly agree” to 5 = “strongly disagree” with higher scores 
indicating better quality of life. The lowest total score possible, indicating poorer quality 
of life, is 49, and the highest is 245. Scores can be calculated for individual domains or 
for the entire scale.  
The 12 domains of the SS-QOL subscales demonstrated high reliability with all 
domains’ Cronbach’s α values ≥0.73 (Williams et al., 1999). In order to develop the SS-
QOL scale, stroke survivors (N=34) were interviewed by a single investigator at one and 
6 months post-stroke. Common domains were identified from the interviews as well as 
from review of other stroke and health related quality of life instruments (Williams et al., 
1999), inductively establishing content validity. Once fully developed, the instrument 
contained 12 domains, and was then used by the same researchers in a different study 
cohort (n=72) of patients with mild to moderate stroke, at one and three months post-
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stroke. Patients were administered the SS-QOL as well as the (SF-36) Barthel’s Index 
(BI), Beck Depression Inventory (BDI), and the Short Form 36 (SF-36) to measure 
construct validity of the 12 domains (Williams et al., 1999). Construct validity was 
established by comparing the linear association of each domain score with the score of 
one of the above established outcome measures. Most overall domains in this initial study 
demonstrated reasonable construct validity. After this initial study, individual items were 
retained if they were responsive to patient-reported change, resulting in the 49 items used 
currently. 
Perception of Symptoms 
Perception of symptoms is a person’s understanding of the different dimensions 
of symptoms he/she is experiencing. The Revised Illness Perceptions Questionnaire 
(IPQ-R) is an instrument that was developed for use with the Common Sense Theory of 
Self-Management (Moss-Morris et al., 2002). The IPQ-R evaluates individuals’ 
perceptions of symptoms and whether they believe the symptoms are related to an illness, 
which in this case is stroke. Researchers are encouraged to change the wording of items 
by changing “illness” to the subject of interest, in this case stroke. The scoring can be 
divided into eight subscales. The first subscale is Identity, represented by 12 items, in 
which participants reply “yes” or “no” to whether they have experienced a list of 
symptoms and then “yes” or “no” if they believe the symptoms experienced are related to 
their stroke. Next are Timeline acute/chronic (6 items), Consequences (6 items), Personal 
control (6 items), Treatment control (5 items), Illness coherence (5 items), Timeline 
cyclical (4 items), and Emotional representations (6 items), which are all scored on a 1-5-
point Likert scale, varying by subscale, with some reverse scored individual items. For 
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example, 1 indicates “strongly disagree” and 5 indicates “strongly agree” in the Identity 
subscale. The last section, Causes, (C1-C18), which is not considered a subscale, assesses 
participants’ subjective views about what might be the possible causes of their illness, in 
this case, stroke. These final 18 questions are coded as causes and are also scored on a 5-
point Likert scale, from 1 “strongly disagree” to 5 “strongly agree”. Participants are also 
asked to rank order the three most important factors they believe caused their symptoms. 
High scores on identity, timeline acute/chronic, consequences and timeline 
cyclical correspond with strong beliefs about how many symptoms participants feel are 
related to their stroke, are chronic symptoms, are negative consequences of their stroke 
and are cyclical in nature. High scores on personal and treatment control and illness 
coherence, indicate that participants feel they can control their symptoms and that they 
have a stronger personal understanding of their condition.  
The IPQ-R was validated using eight illness groups (Moss-Morris et al., 2002). 
Factor analysis was used to validate the factor structure of the 50 items in Part II of the 
instrument using two separate principal component analyses (PAS). This first PAS 
produced 11 factors. The remaining 38 items loaded onto 7 factors of greater than 0.5. 
Nearly all individual items loaded exclusively onto one of the 18 factors. For instrument 
reliability Cronbach alpha coefficients were calculated for each subscale and ranged from 
0.79-0.89. Another PAS was conducted on the 18 causal items and it indicated four 
distinct factors; Psychological attributions, Risk factors, Immunity, and Accident or 
Chance. Cronbach’s alphas on these factors ranged from 0.67-0.86. The Positive and 
Negative Affect Schedule (PANAS), an instrument that measures a person’s enthusiasm, 
activity and alertness, and subjective distress and discomfort, was used to determine 
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discriminant validity using Pearson’s correlations between the subscales of the IPQ-R. 
Correlations were mostly small or moderate with the largest being between the Emotional 
Representations Negative Affect (r=.54) (Moss-Morris et al., 2002). Correlational 
analyses were also performed with The Ambulatory Index, Sickness Impact Profile (SIP), 
and FSS to assess predictive validity and results demonstrated that most dimensions were 
significant predictors of the IPQ-R (Moss-Morris et al., 2002). Test-retest reliability was 
assessed as part of the study validating the IPQ-R, by administering the IPQ-R a second 
time to participants in the rheumatoid arthritis illness group six months after the first. 
Nearly all correlations were >.5. It was also tested at a three-week interval in the renal 
dialysis group. Of the 12 subscales only one correlation was <.5 at .46 and values ranged 
from .46-.88 (Moss-Morris et al., 2002). 
 A shorter, self-administered version of the IPQ-R, the Brief Illness Perception 
Questionnaire (Brief IPQ) was developed to enable rapid assessment of cognitive and 
emotional representations of illness (Broadbent, Petrie, Main, & Weinman, 2006) 
[Appendix E]. Participants completed the Brief IPQ. It was designed to be more useful 
when measuring illness perception as part of a larger group of psychosocial concepts. 
Each of the eight subscales from the IPQ-R are represented by one question on the Brief 
IPQ and are measured on a 0-to-10 response scale. Items 3, 4, and 7 are reverse scored. 
Higher scores reflect a more threatening view of the symptoms. A ninth item corresponds 
to the causal representation question, asking patients to list what they perceive to be the 
three most important factors causing their illness, or in this case, symptoms. 
 Psychometric properties of the Brief IPQ were evaluated using data from six 
illness groups (Broadbent, Petrie, Main, & Weinman, 2006). Test-retest reliability was 
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established at 3-week and 6-week intervals, with Pearson correlations in all eight 
domains P<.001 at 3-weeks and P<.001 in seven of the eight domains at 6-weeks. 
Concurrent validity was assessed in three of the illness populations using correlations 
between the IPQ-R and the Brief IPQ, with results indicating the scales are appropriately 
correlated. Predictive validity was investigated in the Myocardial Infarction (MI) illness 
group, which is similar to stroke in the nature of sudden onset of symptoms and available 
treatments. A MANOVA was performed and the Brief IPQ was predictive of five 
domains at discharge in MI patients and mental and physical ability at three-month 
follow-up: consequences, identity, concern, emotional response, and treatment control. 
Procedures 
After obtaining IRB approval and a partial HIPPA waiver to enable screening of 
potential participants, the researcher reviewed a total of 22 months of closed inpatient 
medical records of YASS who received care at the Stroke and Neuroscience Center of the 
selected hospital. Once deemed eligible based on medical record review potential 
participants were contacted. They were contacted by telephone, email, and/or United 
States Postal Service mail between 1-18 months post-discharge. Text messaging was used 
when contacted by telephone, in which the student principal investigator (PI) informed 
potential participants about the study and ascertained their interest in participating. If they 
were interested, the research procedures were emailed to the potential participant. When 
contacted by email or postal service the first page informed potential participants about 
the study. Participants had an opportunity to ask questions about the study as needed at 
the initial contact and throughout the study. They were informed that their participation 
was voluntary and they could withdraw from the study at any time without penalty 
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including accessibility to and quality of healthcare at the Stroke and Neuroscience 
Center.  
Prior to the start of the study, the four questionnaires were entered into Qualtrics 
and reviewed with a member of the dissertation committee for accuracy and 
functionality. They were then completed by three YASS to validate their clarity and the 
time required to complete them. Typographical and formatting errors were corrected prior 
to sending the Qualtrics link to participants. For those individuals identified as meeting 
inclusion criteria with an email address in the medical record (n=15), emails including a 
link to the Qualtrics surveys were emailed at 1-18 months post-discharge with a reminder 
email sent two weeks and one and two months after the first email contact as needed. 
Additionally, seven email addresses were provided by participants who responded to 
texts and requested the electronic format. The first link on the opening page of the email 
was the study consent form. The second link on the opening page of the email was the 
Qualtrics application with the survey. The language in the consent form indicated that by 
completing and returning the surveys they were consenting to participate. Additionally, a 
hard copy of the study information and survey was mailed to all potential participants 
with a pre-address stamped envelope to return the surveys to the student PI. Paper 
surveys were numbered to match emailed surveys by potential participants, in order to 
prevent any duplication should a participant complete both the paper and electronic 
surveys. 
Once participants completed the online or paper surveys, their responses were 
reviewed by the PI for accuracy and for reported symptoms. A contact telephone number 
for the participant was requested on the survey in order discuss any missing or discrepant 
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data, and to inform participants of high scores suggesting follow up with their physician. 
After completion of the surveys, participants received a personal handwritten thank you 
letter with a $20 gift card. This was mailed to participants at their self-designated best 
address. The total time for participation in the study including survey completion was 
estimated at 30 minutes. 
Data Analysis 
All data were entered in IBM SPSS Statistics version 25 database for the data 
analysis. Demographic data from participants’ medical records were entered into SPSS 
by the researcher. Data collected in the Qualtrics program were transferred to SPSS and 
data from paper responses were entered into SPSS by the researcher. Prior to statistical 
analysis, all data were reviewed to check for errors and missing values. Errors were 
corrected and missing values were addressed.  Data were also checked for normality to 
identify outlying or extreme observations. None were identified. Descriptive statistics 
were performed to describe the characteristics of the sample and the major study 
variables. Measures of central tendency were reported for the demographic and medical 
characteristics of the sample, as well as the standard questionnaire responses. Spearman’s 
correlations were performed to determine bivariate relationships among anxiety, fatigue, 
depression, illness perception and stroke specific quality of life. Open ended question 
responses were evaluated for common themes, and grouped accordingly into four 
response categories. 
Human Subjects Protection 
 The study proposal was submitted to the Institutional Review Board at Georgia 
State University and the Nursing Research Oversite Committee (ROC) at the recruitment 
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site, which is a large, public, academic, safety-net hospital in the Southeastern United 
States, for approval prior to study implementation. Informed consent was obtained by all 
study participants [Appendix F] Strategies were undertaken to maintain confidentiality of 
participants and their data. In addition to the process for consent and enrollment 
discussed previously, a unique identification number was used on all forms and the list 
with participant information and matching unique identification number was stored in a 
locked cabinet in a secure office of the PI. This information was kept separate from the 
associated data. Data were stored on a password protected secure computer in a password 
protected file. Individual contributor information was not contained in the same files as 
the data. When disseminating the findings of the study, the data will be reported in 
aggregate. 
This study involved assessment of the symptoms of psychological illness which 
may require follow up health care. The consent form included a statement that if high 
scores were identified for significant symptoms related to anxiety, depression or fatigue 
participants would be informed by the PI and encouraged to follow up with their primary 
care provider or neurology post-acute care provider. 
 Based on the historical population at the enrollment site, all genders were 
included in the study. Minority populations were significantly represented as they have 
represented nearly 75% of the annual stroke patient volume at this large, public, 
academic, urban hospital. Children were not included in the study as the population of 
interest is adults aged 18-55. Pregnant women were not included in the study. 
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Special Planning and Safeguard Strategies 
While this study population does not fall into a traditionally recognized vulnerable 
population such as pregnant women, children, fetuses, or prisoners, as mentioned above, 
the NIH does include individuals with neurologic diseases, including stroke, to 
potentially have questionable capacity to provide informed consent (NIH, 2009). The first 
special consideration for this study was to consider carefully the cognitive capacity of the 
YASS to consent and to participate in the study. Blackmer (2003) addresses this concern 
in the rehabilitation medicine population, and speaks specifically to stroke, as it is the 
most common diagnosis in this arena. He purports that while many of these patients 
recover neurologically, judgement and reasoning may be impaired and thus they may not 
truly be informed regarding participation. He suggests these individuals undergo 
additional capacity assessment. To address this in the study, the inclusion criteria helped 
to minimize the possibility that at the time of recruitment prior to or soon after discharge, 
these YASS were incapable of decision making. To be considered for participation, they 
had to be discharged directly home and have had no appreciable neurological deficits 
with a mRS of 0-3 and a low NIHSS score. Cognitive screening was a part of the 
standard assessment and treatment of a stroke patient in a Comprehensive Stroke Center, 
and the recruitment site is a certified Joint Commission Comprehensive Stroke Center 
(Facts about Comprehensive Stroke Center Certification, 2017). Confirmation of a 
negative cognitive screen indicating no impairment was included in the record review for 
eligibility before approaching potential participants. 
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CHAPTER IV 
RESULTS 
 The results of this cross-sectional, exploratory study of the presence of 
psychosocial symptoms in young adult stroke survivors post-acute thrombectomy for 
ischemic stroke are presented in this chapter. A summary of the characteristics of the 
sample, responses to the study aims, hypothesis testing, and research questions are 
reported. 
 Figure 2 demonstrates the screening and enrollment data. There were 80 potential 
participants identified through the initial screening process of medical record review of 
all acute strokes presenting to a large, public, academic, safety-net hospital 
comprehensive stroke center in the southern United States, from January 2017 through 
October 2018. Of these YASS, 38 (48%) did not meet eligibility criteria, with the 
majority being excluded for major medical comorbidities, followed by being non-English 
speaking then death. Of the 42 participants who met eligibility criteria, a total of 14 
participants were enrolled in the study. Of the remaining 28 who were not enrolled,  
three declined with no reason, one declined after agreeing to participate but then denied 
having had a stroke, one returned the questionnaires but was outside the window for 
eligibility, and two agreed to participate but never completed the questionnaires. Based 
on the contact information available for each potential participant, attempts were made to 
contact them, but of the remaining 21 potential participants, four sets of questionnaires 
were returned as undeliverable by the United States Postal Service, one text response 
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indicated the telephone number did not belong to the potential participant, and the 
remaining 16 did not respond to three emails, one postal mailing, and two-three telephone 
texts regarding study participation. It is unknown whether the contact information 
provided in the medical record was accurate as it is common for false numbers and 
addresses to be given at the time of hospital registration. 
 
Figure 2. Screening and Enrollment for Young Adult Stroke Survivor Study 
Demographic characteristics of those who were eligible but did not participate (n 
= 38) were nearly identical for race (Black 61%, Caucasian 29%) compared to those who 
did participate, with the exception of three with unknown race and no potential 
participants identified as Asian. The mean age of non-participants was 47.6 (SD=7.8) 
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Potential participants screened for 
enrollment in the study (n=80) 
Eligible n=42 (53%) Not Eligible/Excluded n=38 (48%) 
 Chronic severe CHF (n=14) 
 Previous stroke (n=8) 
 Stage IV cancer (n=4) 
 Major depressive disorder (n=2) 
 Non-English Speaking (n=7) 
 Deceased (n=3) 
Non-participants n=28 (67%) 
 Unable to reach (n=16) 
 Declined (n=6)  
 Incorrect contact 
information (n=5) 
 Responded outside 
eligibility window (n=1) 
 
Eligible participants enrolled  
n=14 (33%) 
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which was similar to the study population with a mean age 45 (SD=6.2). However, the 
non-participants were 64% male, as compared to only 29% male in the study sample 
Data Entry & Screening Procedures 
 Data were collected electronically from 12 of the participants, using the Qualtrics 
application, and two participants who completed and returned paper surveys. Data 
collected in the Qualtrics program were exported to SPSS and data from paper responses 
were entered into SPSS by the student investigator.  Prior to statistical analysis, data were 
reviewed to check for errors and missing values. Errors were corrected, and missing 
values were addressed. Of the 14 participants, 12 completed all questionnaires with two 
having missed a single item on a questionnaire. As the questionnaires require information 
about the participants’ experiences over the past week, they were not contacted due to the 
time delay from original data collection. Two participants completed only the first 
questionnaire, the HADS, however those responses were complete for the major variables 
of anxiety and depression and therefore included in the study. One participant omitted 
one of six questions on the motor subscale of the SSQOL and the case mean substitution 
method was used for mean item replacement to populate the variable. There was also one 
missing response omitted by a participant for the treatment control item of the Brief IPQ. 
As each question on the Brief IPQ represents a domain, this domain could not be 
calculated. However, the other items in the questionnaire for that participant remained in 
the data for individual domain scoring but were not included in the Brief IPQ total score 
variable for this participant.  
Data were also checked for normality to identify outlying or extreme 
observations. Descriptive analysis was performed to determine normality of categorical 
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and continuous data variables, including measures of central tendency, skewness and 
kurtosis, with no abnormalities identified. Major variables under consideration included 
anxiety, depressive symptoms, fatigue, SSQOL and illness perception.  
Characteristics of the Sample 
The sample included 14 participants, with a mean age of 45 (SD = 6.2) years, 
ranging from ages 34-52 years. Women outnumbered men 2.5:1, and the majority of 
participants were African American/ Black (n = 8), with the remaining sample comprised 
of Caucasians (n = 4) and Asians (n = 2). Of the 12 participants reporting on years of 
education, 25% did not complete high school, 8% completed high school with no college, 
25% completed a two-year college program, 33% earned a four-year college degree and 
8% completed a PhD program. Participants were between 4-18 months (M = 12.5) post-
stroke at the time of study participation. There were 43% in the 0-6 month range, 36% in 
the 7-12 month range, and 21% between 13-18 months post-stroke. Of the 11 participants 
reporting on return to work or school, seven were back at work full time, two were back 
part time, and two reported that they were not employed at the time of stroke. 
Clinical characteristics are presented in Table 1 and were normally distributed. 
Nearly half received IV alteplase prior to thrombectomy, had an occlusion in the M1 
MCA, and all had clinically optimal recanalization of the artery (TICI 2b or 3). The pre-
morbid mRS scores were zero for all participants and the discharge mRS was evenly 
distributed (0-3) across this sample indicating equal representation of varying levels of 
independent function. 
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Table 1 
Sample Clinical Characteristics of YASS Participants (N=14) 
Characteristic N (%) 
 
M (SD) 
 
Premorbid mRS 0(100) 
 
 
Discharge mRS 
  
 0 
  
 1 
 
 2 
 
 3 
 
 
 
4(29) 
 
3(21) 
 
4(29) 
 
3(21) 
 
1.4(1.2) 
Arrival NIHSS  10.9(6.2) 
 
Discharge NIHSS  2.0(2.6) 
 
Received alteplase 6(43) 
 
 
Clot location 
 
 M1 MCA 
 
 MS MCA 
 
 ICA 
 
 ICA Terminus 
 
 UTD 
 
 
7(50) 
 
4(29) 
 
1(7) 
 
1(7) 
 
1(7) 
 
 
 
(Table 1 Continues) 
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(Table 1 Continued) 
 
Characteristic N (%) 
 
M (SD) 
 
TICI score 
 
 Grade 2b 
 
 Grade 3  
 
 
 
5(36) 
 
9(64) 
 
mRS=modified Rankin Scale Score, NIHSS=National Institutes of Health Stroke Scale, 
MCA=middle cerebral artery, ICA= internal carotid artery, UTD=unable to determine, 
TICI= Thrombolysis in Cerebral Infarction Scale with 2b and 3 being successful 
reperfusion 
 
Reliability of Instruments 
 As previously stated, there were four questionnaires used to gather data from the 
participants in this study: the HADS, FSS, SS-QOL, and the Brief IPQ. Reliability testing 
for internal consistency was calculated for each questionnaire including item-level 
statistics and reported using Cronbach’s Alpha. The alpha coefficients for the instruments 
are reported in Table 2. 
Table 2 
 
Descriptive Statistics and Cronbach’s Alpha of the Major Variables 
 
 
n M SD 
Actual  
Min-Max 
Possible  
Min-Max 
 
Cronbach’s 
Alpha 
 
Anxiety 
(HADS) 
 
14 4.57 3.39 1-13 0-21 .69a 
Depression 
(HADS) 
 
14 4.43 3.63 0-12 0-21 .72 
 
(Table 2 Continues)  
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(Table 2 Continued) 
 
n M SD 
Actual  
Min-Max 
Possible  
Min-Max 
 
Cronbach’s 
Alpha 
 
       
       
Fatigue 
(FSS) 
 
12 4.00 1.91 1-7 1-7 .95 
Quality of 
Life 
(SSQOL) 
 
12 185.67 44.47 110-243 49-245 .97 
Illness 
Perception 
(Brief IPQ) 
11 30.73 15.93 12-68 0-80 .63 
a. When total HADS instrument reliability calculated including depression and anxiety, 
Cronbach's Alpha is .84 
 
Descriptive Statistics of Major Study Variables 
 The major study variables described in this section are anxiety, depressive 
symptoms, fatigue, SSQOL and illness perception. Descriptive statistics for each variable 
are presented in Table 2. 
The HADS literature purports that anxiety and depression are not present if the 
subscale score is ≤ 7, borderline if between 8-10, and definite for scores >10, with 
potential scores between 0-21. For the anxiety component, this sample had one borderline 
(subscale score = 10) and one definite (subscale score = 13) case. For the depression 
component, there were three borderline cases (subscale scores = 8,8,9) and one definite 
(subscale score = 12) case. For the FSS, clinically significant fatigue is represented by a 
score ≥ 4, and 42% (n = 5) of participants had a score ≥ 4. There were three borderline 
cases of fatigue (scores = 3.3, 3.4, 3.6). 
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Total SS-QOL scores can range from 49-245, with higher scores indicating better 
quality of life. The total mean score for this sample was 186 (SD = 44). This mean is 
below the midpoint of the scale. Subscale scores can range from 1-5 with higher scores 
also indicating higher quality of life (Table 3). Two subscale domains, personality (M = 
2.89) and thinking (M = 2.92), fell below the midpoint of the scale. Descriptive statistics 
for the SS-QOL subscales are presented in Table 3. 
Table 3 
 
Descriptive Statistics of Stroke Specific Quality of Life (SSQOL) Subscales (n = 12) 
 
Subscale Domain  M SD Actual 
Min-Max 
Personality 2.89 1.45 1-5 
Thinking 2.92 1.38 1-5 
Social roles 3.15 1.29 1-5 
Energy 3.47 1.34 1.3-5 
Language 3.48 1.30 1-5 
Family 3.72 1.20 1.7-5 
Mobility 3.76 1.31 1.7-5 
Mood 3.80 1.17 1-5 
Work/productivity 4.28 1.03 1.7-5 
Upper extremity 4.38 1.02 1.4-5 
Vision 4.53 0.66 3-5 
Self care 4.78 0.57 3-5 
 
The Brief IPQ scores can range from 0-80 with higher scores indicating a more 
threatening view of the illness. This mean score among this sample was 30.7 (SD=15.9), 
which was below the midpoint of the scale. However, when looking at the individual 
items representing the domains on a 0-10 scale, four domains ranged from 4.08 to 4.42. 
These individual domain scores indicate a moderate threatening illness perception of the 
consequences, treatment control, concern and emotion domains. Descriptive statistics for 
the Brief IPQ domains are presented in Table 4. 
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Table 4 
Descriptive Statistics of the Brief Illness Perception Questionnaire (IPQ) (n = 12) 
 
Domain M SD 
Actual 
Min-Max 
Consequences: How much do your symptoms affect your life? 4.42 2.91 0-8 
Timeline: How long do you think your symptoms will continue? 3.25 3.49 0-10 
Personal Control: How much control do you feel you have over 
your symptoms? 
3.67 3.03 0-10 
Treatment Control*: How much do you think your treatment 
can help your symptoms? 
4.27 3.98 0-10 
Identity: How much do you experience symptoms from your 
stroke? 
3.50 3.32 0-10 
Concern: How concerned are you about your symptoms? 4.25 3.19 0-10 
Emotional Representation: How much do your symptoms 
affect you emotionally (do they make you angry, scared, upset or 
depressed)? 
 
4.08 3.34 0-10 
Coherence: How well do you feel you understand your 
symptoms? 
2.67 2.31 2-10 
*(n = 11) 
Research Questions 
Research Question 1: What are the most common symptoms reported by 
YASS, between one and eighteen months post-stroke? 
Based on the three targeted psychosocial variables (i.e. anxiety, fatigue and 
depression), fatigue was the most prominent symptom reported. Five participants were 
experiencing clinically significant fatigue, while fewer were experiencing clinically 
significant anxiety (n =1) or depression (n = 1).  
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Participants listed in rank-order the three most important factors they believe 
caused their symptoms. This question was answered by 78% of participants. Possible 
contributors to fatigue were also observed in these responses. Participants reported 
medications (n = 3) as the cause, functional items (i.e. fatigue, sleeping habits, too much 
or hard work) (n = 5), and poor self-care (n= 4), including eating habits, not taking care 
of body, and too long standing. Participants also described physiological symptoms that 
included eye sight changes (n = 1), cognitive (memory) issues (n = 1), numbness of the 
face and arm (n = 1), “vein had a dent” (n = 1), flu (n = 1), and weakness (n = 1). Only 
three participants indicated that stroke caused their symptoms. 
Lastly, there was one open-ended question where participants were asked to share 
anything else that they would like the student researcher to know about their stroke 
experience. Six of the 12 participants included a response for this question. Responses are 
categorized in Table 5.  
Table 5 
Stroke Experience Comments Categorized 
Physical Religious Faith Gratitude 
 
Education 
 
“A slow start” 
“Too fast” 
“I’m a Christian, 
and I believe I was 
healed with the 
grace of God” 
“I believe I was 
very lucky to have 
such an attentive 
team” 
“I don’t believe I 
was educated well 
enough on what 
happened to me” 
 
 
(Table 5 Continues) 
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(Table 5 Continued) 
 
Physical Religious Faith Gratitude 
 
Education 
 
“Always trying to 
push forward” 
“Trying hard” 
“I want to suggest 
that you may think 
about the influence 
of faith on stroke 
patients” 
 
“Everyone worked 
quickly starting 
from my daughter 
calling 911” 
“Once I got home 
and back to work, I 
realized things were 
not back to normal” 
“Hot spot rear of 
head Loss of sight-
peripheral vision 
left eye” 
 
 
“God is good…” “…and so is 
Grady’s stroke 
unit” 
“There is a 
difference in what 
information the 
doctors think is 
important versus 
the patient” 
 
“Stroke on right 
side of body” 
“Memory is gone” 
“Fatigue” 
“Shortness of 
breath” 
“Headache 
Migraines” 
 
  “Uneducated in this 
and not being able 
to search online, 
read, process, etc.” 
“Right side motor 
skills not as strong 
as left” 
 
   
 
Research Question 2: What are the relationships among clinical variables 
(NIHSS, mRS) anxiety, fatigue, depressive symptoms and stroke specific quality of life, 
in YASS? 
The relationships among these variables were examined using Spearman’s rho 
correlations and the data are presented in Table 6. The nonparametric Spearman’s rho 
was calculated, due to the small sample size of 11-12, and rs values ranged from -.623 to 
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.735. The correlation analysis was for exploratory purposes and the results should be 
interpreted with caution due to the small sample size (Polit, 2010). 
  There were no significant relationships (p>.05) identified between clinical 
variables, including discharge mRS scores (rs values ranged from -.237 to .288) and 
arrival NIHSS scores (rs values ranged from -.196 to .376) and the primary psychosocial 
variables of interest. However, there were significant correlations found among the 
psychosocial variables examined. There was a significant relationship between anxiety 
and depression, with increased anxiety associated with increased depression. However, 
anxiety and depression were not related to fatigue and illness perception was not related 
to anxiety, depression or fatigue. Anxiety, depression, and fatigue scores were found to 
have an inverse relationship with SSQOL. Higher anxiety, depression and fatigue were 
associated with lower SSQOL. Additionally, greater perceptions of the threat of 
symptoms (higher score means more threatening view) were associated with lower 
SSQOL. Overall the findings were consistent indicating the more severe the psychosocial 
symptoms, the lower the SSQOL. 
Table 6 
Relationships among Major Study Variables 
Measure 1 2 3 4 5 
1. Quality of Life 
 
− -.65*      -.74**   -.73** -.62* 
2. Anxiety 
 
-.65* −      .68** .19 .47 
3. Depression 
 
-.74**      .68** − .50 .26 
4. Fatigue 
 
-.73** .19 .50 _ .38 
5. Illness Perception    -.63* .47 .26 .38 − 
 
*. Correlation is significant at the 0.05 level (2-tailed).   
**.Correlation is significant at the 0.1 level (2-tailed). 
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 Research Question 3: What do YASS report are the identity, timeline, causes, 
consequences and control of post-stroke symptoms of anxiety, fatigue and 
depression between one and eighteen months post-discharge? 
The Brief IPQ captures the subscales of the Common Sense Model, and the 
results of the eight subscales are reported in Table 4. Scores of zero indicate no threat of 
the symptoms while scores of 10 indicate a highly threatening view of symptoms. The 
mean response in four of the items (i.e. consequences, treatment control, concern, and 
emotional representation) was >4, indicating a moderately threatening perception of those 
domains. None of the items on the Brief IPQ had a mean score of zero, indicating that in 
all domains there was some perception of threat from their post-stroke symptoms. 
Hypothesis Testing 
 Hypothesis 1: Levels of anxiety, fatigue and depression will be elevated in YASS
 This hypothesis was tested using the HADS and the FSS to screen for levels of 
anxiety, depressive symptoms and fatigue. Elevated was defined according to 
questionnaire cutoff scores. When using the criteria associated with these instruments, the 
HADS results indicated only one each of definite cases of anxiety and depression, and the 
FSS indicated that five (42%) participants had severe fatigue.  
 Hypothesis 2: Higher levels of anxiety, fatigue, depression, and illness threat 
perception will be associated with lower stroke specific quality of life. 
 This hypothesis was tested by performing Spearman’s rho bivariate correlations 
between psychosocial variables (i.e. anxiety, depression, fatigue), and SSQOL. 
Statistically significant results were observed that indicated strong correlations between 
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each psychosocial variable and SSQOL, such that higher anxiety, depression, fatigue, and 
illness threat perception were associated with lower SSQOL. 
Summary 
 Chapter IV has presented the results of this non-experimental, cross-sectional, 
exploratory study to examine relationships among clinical and demographic 
characteristics, psychosocial variables and quality of life in YASS who were treated with 
intravenous alteplase and/or mechanical thrombectomy, had minimal physical deficits 
and were discharged directly to home after acute stroke. In this small sample of YASS 
who had limited to no deficits following stroke, levels of anxiety and depression were 
low, but fatigue levels were elevated in almost half the sample. SSQOL was reduced and 
all three of the psychosocial variables were significantly associated with SSQOL. Illness 
perceptions as measured with the Brief IPQ indicated a moderately threatening view of 
their symptoms, and as the threat increased, SSQOL decreased. Open-ended responses 
suggested that participants may not understand potential symptoms post-stroke. 
 
 
58 
 
CHAPTER V 
DISCUSSION AND CONCLUSION 
 Chapter V presents a discussion of the findings from this cross-sectional, 
exploratory study examining the common symptoms, perception of illness, and the 
presence of and relationships among psychosocial variables (anxiety, depression, and 
fatigue), and their relationship to stroke specific quality of life in YASS. A discussion of 
the findings in relation to prior literature and the Common Sense Model are included 
along with a description of the study limitations, strengths of the study, implications for 
nursing practice, and recommendations for future research. 
Demographic Characteristics of Young Adult Stroke Survivors 
Nearly 25% of the growing population having new onset of strokes are under age 
65, with 34% of hospitalized stroke patients in 2009 under age 65 (Stroke Facts, 2019). 
With the widening availability of technology and skilled providers, more young adults 
experiencing large vessel stroke are receiving treatment, and rapidly recovering from 
severe neurological symptoms. Many of these YASS are discharged directly from the 
hospital to home because they have few to no apparent neurological deficits. However, 
findings from this study suggests that these YASS do not escape post-stroke symptoms, 
in spite of their rapid functional recovery.  
The sample in this study was smaller than the originally projected 30 participants, 
as it was an unexpected finding that 38 of the potential 80 YASS fell into categories 
within the exclusion criteria, with the majority having a significant co-morbidity (e.g. 
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congestive heart failure, depression) or previous stroke. This level of pathology was 
unexpected in a young and functionally independent population, and reduced the pool of 
eligible candidates for recruitment. The 14 participants in this study were in a normal 
state of health prior to experiencing their stroke, with 79% reporting working full time 
prior to their stroke and no documented chronic health conditions. In terms of function 
and independence prior to hospitalization for stroke, all study participants had no 
neurological deficits with a premorbid mRS score of zero. Eligibility for thrombectomy 
requires a large vessel occlusion (LVO) with an ischemic penumbra at risk for further 
infarction. Of these YASS, 86% presented to the acute hospital with moderate to severe 
stroke symptoms (NIHSS ≥5), with a mean NIHSS score of 11. 
Of the nine participants who were working prior to their stroke and responded to 
the work question, 100% were back to work, 78% full-time. As compared to other studies 
reporting on return to work in YASS, this indicates a higher percentage and may be 
attributed to the thrombectomy and subsequent reduction in functional disability. 
Anderson et al. (2012) studied return to work in 83 YASS ages <60 with first ever stroke, 
who were employed full or part time at baseline. The percentage who had returned to 
work at least part-time (10 hours minimum) or full-time was 53% at year one and 58% at 
year two. Hommel et al. (2009) assessed social dysfunction in 84 first-ever mild to 
moderate stroke survivors who were of vocational age, defined as 18-64 years old. They 
were assessed at three and nine months post stroke (median 7 months) and had no 
apparent severe neurological deficits, with an NIHSS <4 and mRS score ≤2. Of this 
sample, 59% had returned to work. Yet, for those who do return to work, more 
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information is needed on their work experience and whether post-stroke symptoms 
impede work ability.  
Race/ethnicity and years of education among the participants in the study 
represented a broad range, with three racial/ethnic groups represented and education 
distributed from less than high school education to PhD degree. Stroke related to LVO 
impacts individuals of different race/ethnicities, education level and gender and therefore 
the study of the phenomenon of YASS being discharged home cannot be limited to a 
specific group. However, as men were under represented in this study, they may be less 
responsive to research participation or follow up. Data for non-participants showed that 
African American men were most likely not to participate, which is of concern as young 
African American males are at highest risk for stroke than other racial/ethnic groups 
(Benjamin et al., 2018).  
Challenges in Recruiting Young Stroke Survivors from a Public Hospital 
The most challenging barrier to recruitment was the inability to contact and/or 
lack of response from potential participants. It is unclear whether the efforts to contact 
participants reached them and they chose to not to respond or if they did not receive the 
invitations to participate. In spite of multiple attempts (2-3) and methods (telephone, 
United States Postal Service, email) to contact eligible patients, most non-participants 
could not be contacted or did not respond to attempts made to contact them. Some of this 
was attributed to incorrect mailing addresses and telephone numbers as well as absence 
of email addresses in the medical record. Challenges to capturing accurate information 
may be attributed to the emergent arrival and immediate treatment of patients being 
transferred from other hospitals without family present, inability to verbally communicate 
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upon arrival, and inconsistency among registration processes dependent on location of 
entry to the hospital. Additionally, as the time of contact was between 1 – 18 months 
post-stroke, these YASS may have been too remote from the event to want to participate, 
or have moved or experienced other health events or life challenges preventing 
participation. For example, one male YASS returned the paper survey by mail nine 
months after recruitment efforts, indicating he would have sent it sooner, but he was in 
jail. His responses were recorded 24 months post-stroke therefore could not be included 
in the study. There is the possibility that the remainder of those unable to be contacted 
were simply not responding to the requests because of lack of interest, not wanting to 
share their experiences and/or participate in research. The hospital where participants 
were recruited, treats a highly vulnerable population, and the challenges faced by this 
population may result from this.   
 There were three non-participants that originally expressed interest in 
participating but when provided with the questionnaires by mail or email, never 
completed the questionnaires. One potential participant in particular, followed up after 
receiving the study information stating “Yes ma’am I don’t qualify” and “I’ve never had 
a stroke”. This may represent a fundamental lack of understanding of the stroke diagnosis 
as the medical record indicated that the individual had a stroke with treatment for large 
vessel occlusion. For the two others, they may not have thought the information was 
relevant to them; again, potentially indicating a lack of understanding of stroke, in this 
case recovery. Additionally, the questionnaires may have contained information that they 
were uncomfortable sharing due to the sensitive nature of this study and personal 
information regarding wellness, even though it was anonymous. Based on the 
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demographic characteristics of the sample of interest and challenges identified with 
recruitment for this study, strategies are needed to reach and engage all YASS for stroke 
recovery education and follow up. 
Levels of Anxiety, Depression, and Fatigue in Young Adult Stroke Survivors 
 The hypothesis that levels of anxiety, depression and fatigue will be elevated in 
this population of YASS as evidenced by definitive cases identified with questionnaire 
cutoff scores, was partially supported by the data. Levels of anxiety and depression were 
not high; there was only one definitive case of anxiety and depression (in the same 
participant), one borderline case of anxiety, and three borderline cases of depression. The 
participant with depression and anxiety was mailed information about following up with 
a healthcare provider. The hypothesis was specific to results on the HADS and this 
population had results below the level of clinical significance. It is possible those free of 
depression and anxiety may have had more motivation and a higher comfort level leading 
them to complete the questionnaires. Potentially, the non-participants had higher levels of 
anxiety and depression and chose not to participate.  
In general, depressive symptoms are common post stroke; one-third of stroke 
survivors develop post-stroke depression (Hackett & Pickles, 2014). Broomfield et al. 
(2014) examined community dwelling survivors of stroke and transient ischemic attack 
(n = 4,079), and using the same HADS criteria, determined that 24% had probable or 
possible depression, which is similar to the 29% having borderline cases of depression in 
this study. The same group had 29% with probable or possible cases of anxiety, which is 
double as compared to participants in this study. De Bruijn et al. (2015) found that 31.9% 
of YASS >1-year post stroke reported anxiety on the HADS. However, Hommel et al. 
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(2009) found low anxiety levels in 18-64 years of age stroke survivors who were 3-9 
months post-stroke. With the findings from this dissertation, (i.e. one participant having a 
definitive case of depression and three borderline, and one definitive anxiety case with 
one borderline), it may be important to screen and follow up for depressive symptoms 
and anxiety in this YASS population. Levels of fatigue were high as evidenced by almost 
half the sample (42%) who completed the FSS (n =12) having severe fatigue, and 21% 
falling just below the cutoff score of ≥4. 
Fatigue as a Common Symptom of Young Stroke Survivors 
 Based on the three targeted psychosocial variables (i.e. anxiety, fatigue and 
depression) assessed, fatigue was the most prominent symptom reported by the YASS. 
The prevalence of fatigue is consistent with the literature which indicates up to half of all 
stroke survivors experience fatigue (Hinkle et al., 2017) whereas one third of stroke 
survivors experience depression (Hackett & Pickles, 2014). Naess & Nyland (2013) 
evaluated post-stroke fatigue and its relationship to mortality in young adult ischemic 
stroke survivors of first ever stroke, and their utilization of the FSS yielded a mean score 
of 4.0 at the six-year and twelve-year follow-up after index stroke. This is identical to the 
occurrence of reported fatigue in the current study and may indicate fatigue is a chronic 
problem long after the acute recovery phase from stroke. Other studies of YASS with 
varying levels of stroke severity and periods of time, found a percentage of participants 
with clinically significant levels or excessive levels of fatigue ranging from 31.1% to 
57.8% (de Bruijn et al., 2015; Egerton et al., 2015; Palmcrantz, Holmqvst, & 
Sommerfeld, 2014).  
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What is clear from these comparisons is the presence of severe fatigue in YASS, 
and that fatigue may be problematic for this population of stroke survivors that has not 
been widely studied. The fatigue is prevalent as early as one-month post-stroke and may 
linger. For young adults this fatigue is particularly problematic as they are more likely to 
be in school, working, raising children, and caring for aging parents. Fatigue can interfere 
with the ability to engage in daily activities which could diminish overall function and 
quality of life. 
Description and Perception of Post-Stroke Symptoms 
The Common Sense Model of Self- Regulation is supported with instruments 
including the Brief IPQ, that evaluate individuals’ perceptions of symptoms and whether 
they believe the symptoms are related to an illness, which in this case is stroke. Higher 
scores on the Brief IPQ indicate that individuals perceive their illness, or in this case, 
symptoms, as more threatening.   
The responses to the Brief IPQ indicated that the level of threat across all eight 
domains was greater than zero; they were experiencing some threat for every domain.  
All YASS in the study reported varying symptom severity levels, but four theory domains 
out of the eight demonstrated mean values near the midpoint of the scale, indicating a 
moderately threatening view for these domains. These domains represented how much 
the YASS perceived that their symptoms affected their lives, how much treatment may 
help their symptoms, how concerned they were about their symptoms, and how much 
their symptoms affected them emotionally. Essentially, the YASS in this study all 
reported symptoms, and with increasing severity, a subsequent reduction in stroke 
specific quality of life scores. These results are of great concern as it is evident these 
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YASS are experiencing symptoms that they perceive as threatening. The results indicate 
these YASS may be experiencing symptoms that moderately affect their lives, that they 
feel may be only moderately treatable, that affect them emotionally and that they are 
concerned about. Most of these individuals have returned to work yet they report 
concerning symptoms that they may not have a strong belief can be managed.  
Groeneveld et al. (2019) examined illness perceptions and their association with 
physical and mental health in 184 Dutch stroke survivors (mean age 61.1; SD = 12.7) at 
three and 12 months after start of rehabilitation post-acute stroke. IPQ domain scores 
were higher for consequences than the YASS in this study which may be a reflection of 
the greater physical disability experienced by those requiring a stay in inpatient 
rehabilitation.  However, at 12 months the treatment control (M = 4.5, SD 3.2), concern 
(M = 5.1, SD 2.8), and emotional response (M = 4.6, SD 2.8) were similar to the YASS in 
this dissertation study: (M = 4.3, SD 3.9; M = 4.3, SD 3.2; M = 4.1, SD 3.3, respectively). 
Patients reported many of the same items as causes of their stroke as were reported by the 
YASS in this sample, including stress, lifestyle and blood vessel malformation and 
medications. 
Participants had a broad range of symptoms and symptom attribution. Participants 
were asked to: “think about symptoms since you had your stroke”, and an open-ended 
question followed asking them to rank-order the three most important factors that they 
believed caused their symptoms. Only three participants reported that their symptoms 
resulted from stroke. Rather than explain what they thought caused their symptoms, many 
participants listed actual symptoms as well as possibly the reasons they thought they had 
a stroke. The responses, in conjunction with the answers to the open-ended item about 
66 
 
 
 
sharing anything else they would like the student PI to know about their stroke, point to a 
knowledge deficit regarding their symptoms and the pathology of stroke or a 
misunderstanding of the symptom attribution question. Causal responses included 
symptoms were from medications, “left vein having a dent”, a hemorrhage, functional 
items such as overdoing it and hard work, poor self-care, and simply unknown, which 
may indicate a lack of understanding of the relationship between the sequelae of stroke 
and their own symptoms. Answers to the open-ended component of the Brief IPQ 
indicated that the symptoms are mostly not being attributed to their strokes. This is 
concerning as it may indicate a fundamental lack of understanding of their diagnosis, 
recovery, treatment options and resources to optimize the transition back to the 
community. Ideally, a YASS with no apparent neurological deficits who discharged 
home from the hospital would be symptom free, and form an illness perception that is 
grounded in factual clinical information about their disease process. This would assist the 
individual in identifying and responding to any subsequent symptoms appropriately. 
These stroke survivors may require ongoing educational resources and support available 
for an extended recovery period, and successful transition back to the community.    
Analysis of the open-ended responses, regarding anything else they would like us 
to know about their stroke experience, yielded four themes; physical, religious faith, 
gratitude, and education. The physical comments reflect the level of understanding of, but 
also point to a presence of, ongoing physical symptoms. Religious faith and gratitude 
reflect belief in a power and trust in and appreciation for caregivers. Both may be 
leveraged in supporting the YASS, as those who have faith and trust may be more likely 
to participate in their recommended plan of recovery (Seagraves, 2017). Lastly and of 
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great importance, the theme of education. One participant succinctly stated what could be 
gleaned from this study: “I don’t believe I was educated well enough on what happened 
to me. Once I got back home and back to work, I realized things were not back to normal. 
There is a difference in what the doctors think is important versus the patient”. 
Relationships Among Anxiety, Fatigue, Depression, Illness Perception and Stroke 
Specific Quality of Life 
 Hypothesis two predicted that higher levels of anxiety, fatigue, depression, 
threatening illness perception would be associated with lower stroke specific quality of 
life. This hypothesis was fully supported by the data. Despite the small sample size, there 
were significant correlations found for the psychosocial variables examined. Higher 
levels of anxiety, depression and fatigue were significantly associated with lower stroke 
specific quality of life. Greater perceptions of the threat of post-stroke symptoms (higher 
score means more threatening view) also were significantly associated with lower stroke 
specific quality of life. Further analysis revealed that anxiety and depression were also 
significantly correlated; the higher the anxiety, the higher the depression. However, 
fatigue was not associated with depression or anxiety. 
Stroke specific quality of life was less than ideal in this sample of YASS and the 
psychosocial variables of interest may help to explain this finding. With a possible score 
of 49-245, the overall mean for SSQOL was 185.67. The means of the twelve individual 
subscales of SSQOL, which are scored on a 1 – 5 scale, ranged between 2.89 and 4.78, 
with two below the midpoint of the scale. This indicates moderate agreement that they 
have problems in the areas of personality and thinking, with negative personality changes 
and lessened ability to remember and concentrate. Both of these may be precursors to the 
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development of depressive symptoms and anxiety in YASS. The domains most closely 
aligned with the variables of interest (anxiety, depression and fatigue), energy (M = 3.47) 
and mood (M = 3.8), reflected that participants moderately disagreed with statements that 
would indicate agreement with fatigue and depression. However, only three participants 
strongly disagreed on all mood items, and only one participant strongly disagreed on all 
energy items. The SSQOL scores reflect the prevalence of less than ideal scores in all 
subscales for stroke specific quality of life, with domains (e.g. personality, thinking, 
social roles) representing psychosocial and cognitive symptoms having lower scores than 
domains (e.g. self-care, vision, upper extremity) representing physical symptoms. The 
findings for levels of SSQOL in young adults, particularly post-thrombectomy, adds to 
the limited literature and suggests further exploration is needed.  
The findings for the relationships between psychosocial variables and quality of 
life are consistent with the literature in other groups of YASS, as the levels of anxiety, 
fatigue and depressive symptoms increase, the stroke specific quality of life decreases. In 
a study examining quality of life after young stroke, de Bruijn et al. (2015) found that the 
presence of fatigue, depression and anxiety were significantly associated with lower 
quality of life scores in the psychological domain. Donnellan, Hickey, Hevey, & O’Neill 
(2010), found that at one month and one-year post-stroke, anxiety and depression 
symptoms were significantly associated with poorer health related quality of life in a 
cohort of adult stroke survivors (n = 107). Guajardo et al. (2015) also found that 
depressive symptoms and health related quality of life were correlated at three months 
post-stroke in adult stroke survivors (n = 67). For fatigue, the American Heart 
Association recommends including the measurement of quality of life in studies of post-
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stroke fatigue as fatigue has been found to significantly affect quality of life (Hinkle et 
al., 2017). Increased perceptions of the threat of symptoms, as measured by the Brief 
IPQ, was also associated with lower SSQOL. Groeneveld et al. (2018) examined the 
relationship of stroke and aphasia specific quality of life with illness perception but in the 
context of physical and communication components and not psychosocial symptoms. 
There has been limited examination of this relationship in the literature and this should be 
explored in future studies as indicated by the symptoms in these YASS. Despite being 
physically intact, participants in this study identified some troubles with their quality of 
life, suggesting that help is needed. With psychosocial symptoms being associated with 
quality of life and these symptoms being perceived as threatening, improving the 
symptoms may improve quality of life.  
There was a strong, significant correlation between anxiety and depression, which 
has been observed in other studies examining these concepts with the HADS instrument. 
In a study by Stein et al. (2018) of 55 ischemic stroke survivors 6-12 months post-stroke 
who were discharged to home or acute rehabilitation with minimal neurological deficits, 
five of the seven patients with anxiety were found to also have depression, and those with 
anxiety and depression were found to have a lower quality of life.  Groeneveld et al. 
(2019) found that anxiety at 12 months was also significantly associated with depressive 
symptoms and anxiety at three months. Although related, anxiety and depression are 
different disorders characterized by different symptoms and one does not suggest the 
presence of the other, therefore both should be assessed. 
Fatigue was not associated with anxiety or depression in the YASS.  However, 
some literature suggests a relationship exist between these variables. In the study by de 
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Bruijn et al. (2015) described earlier, the presence of excessive fatigue correlated with the 
presence of depression and anxiety disorders. This finding may not have been observed in 
the YASS sample due to the small sample size, minimal neurological deficits that impact 
function, and length of time of recovery from stroke. Despite this, assessing YASS for all 
three symptoms during the post-stroke recovery period is warranted to determine where 
to intervene. Illness threat perception was not associated with anxiety, fatigue or 
depression in the YASS study. Due to limited prior research, these associations should be 
explored further along with other potential symptoms YASS may experience post-stroke. 
Lastly, of interest was the finding that the NIHSS on admission and follow-up 
mRS were not correlated with quality of life. This finding regarding physical function 
and quality of life is consistent with the results of the study by de Bruijn et al. (2015), 
who also examined young stroke survivors following non-severe stroke. This may 
indicate that the initial extent of neurological dysfunction as well as residual functional 
disability are not associated with the presence of the psychosocial variables of interest, 
and that stroke specific quality of life may be negatively impacted irrespective of 
physical disability.  
Strengths of the Study 
 With the exception of gender, the participants in the study represented a 
demographically diverse sample reflective of the age, race, level of education, and 
clinical presentation of the greater population of the enrollment site. Based on the data 
available in the American Heart Association’s Get With the Guidelines (GWTG, 2019) 
database and interviews with one of the founders and past presidents of the Society of 
Vascular and Interventional Neurology, R. G. Nogueira (personal communication, May 
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10, 2019) this hospital has the highest volume per site in the United States of stroke 
thrombectomy procedures, with a young, economically and racially diverse emergent 
patient population from urban, suburban, and rural areas. 
 Questionnaires selected were all reliable and valid based on published instrument 
development and utilization research, concise in the clarity and small number of 
questions, and widely utilized in the stroke patient population prior to the current study, 
allowing for comparisons with the literature. The majority of the reliability coefficients 
for this study were adequate. The open-ended questions allowed for additive content 
allowing for exploration outside of the standardized questionnaires, particularly in 
helping to understand potential knowledge deficits. The Brief IPQ was adapted for stroke 
patient symptoms and this may contribute to the literature supporting use of the 
questionnaire in this population.  
 The study investigated a phenomenon that is fairly novel, based on the new 
treatments for stroke and lack of literature available with regard to the concerns for 
psychosocial symptoms in this specific YASS patient population. This patient population 
is increasing exponentially as the technology and trained providers disseminate and 
expand availability and successful treatment rates. This study yielded results that will 
contribute to the literature and begin to address this gap in research and clinical practice. 
Limitations of the Study 
 Caution must be taken when interpreting the results of the study because the 
sample size was small; there were fewer than the proposed target of 30 participants (n = 
14), and two did not complete all questionnaires. Although statistically significant 
relationships were found among the variables, the small sample size threatens the 
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reliability of the results. Additionally, the participants were recruited from a single 
hospital in the stroke belt of the southeastern United States. Therefore, findings from the 
study may not be generalizable to all YASS with similar clinical experiences. However, 
the study provides a basis for a larger study of this understudied phenomena. 
 The questionnaires selected for this study instructed participants to consider their 
experiences over the previous week. As participants were recruited between one and 
eighteen-months post-acute stroke, it is possible that they may have had different 
responses at different time points during their recovery. Therefore, the psychosocial 
variables of interest can only be interpreted for this study at the time of participation. 
Clinically significant levels of anxiety, fatigue and depression may have occurred earlier 
during the recovery period, and not captured with this study design. For those participants 
who experienced stroke more recently, they may still develop symptoms later in 
recovery. It is also unknown if participants were taking medications to manage symptoms 
of post-stroke anxiety or depression and therefore may have had scores reflecting levels 
with treatment. 
 Participants completed the brief IPQ and there is a possibility that they 
misunderstood the open-ended question asking them to list the top three items in rank 
order that they believed caused their symptoms. It is possible they misinterpreted the 
questions a most listed symptoms that they were experiencing and only three attributed 
symptoms to stroke.   
 Lastly, while similar for age and race, the gender of the group of patients that 
participated in the study differed from those who were eligible but did not participate. 
Men were underrepresented in the participant group as only 29% (n =4) of those 
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participating were male and 64% (n = 18) of non-participants were male. This further 
limits generalizability to male YASS. 
Implications for Nursing Practice with the Common-Sense Model 
 This study adds to the body of research about the experiences of YASS, as there is 
little known about the psychosocial symptoms in recipients of the relatively new and 
widely available thrombectomy procedure for large vessel acute ischemic stroke. Existing 
studies that evaluate the recovery of thrombectomy patients focus on functional outcomes 
and include all ages of adult stroke survivors.  How people recognize, interpret and 
respond to their illness or symptoms is based on their existing knowledge and 
experiences which have caused them to form an illness representation. This study 
suggests that this population of YASS may experience symptoms following stroke and 
perceive these symptoms as a threat. As healthcare professionals, nurses are on the 
frontline and can use the proponents of the Common-Sense Model of Self-regulation to 
guide interventions designed to educate and prepare YASS for the months or potentially 
years after their stroke. Using information about the experiences of other YASS, nurses 
can prepare YASS for the possible psychosocial symptoms that they may experience and 
help to reduce the threatening perception of those anticipated symptoms (Howell et al., 
2013). Strategies can be developed, and resources provided for recognition and 
management of post-stroke symptoms. Sources of support can be identified in order to 
provide ongoing interventions for a favorable outcome including improvements in stroke 
specific quality of life. 
 Notably, the most prominent symptom identified in the participants in this study 
was fatigue. The American Heart Association published a scientific statement on post-
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stroke fatigue (Hinkle et al., 2017). In their review of the literature they found that 
available materials about fatigue just include practical advice without sources or 
references from evidence-based published guidelines. The authors concluded that 
evidence-based education regarding fatigue is needed. 
 Typical follow-up for post-thrombectomy patients occurs at around 90 days post-
discharge. These patients may benefit from follow-up at 2-4 weeks, which is the 
timeframe when patients with smaller strokes and TIA are seen in the outpatient clinic 
environment. This may allow for early screening and assessment of potential 
psychosocial symptoms and social support systems. 
Recommendations for Future Research 
Inclusion Criteria 
One notable finding with the study inclusion criteria was that during review of the 
medical records of potential participants, initial screening criteria were met for age, 
treatment and discharge directly to home, but upon further review, almost half (38 out of 
80) were excluded, with 74% of those excluded having major medical comorbidities. 
Broadening inclusion criteria to include this chronically ill population may yield 
important information for management of their illness perception prior to discharge 
home, although delineating the cause of some symptoms between stroke and other 
comorbidities may be difficult. While the aged 18-55year old population was the target of 
this study, there are significant numbers of older stroke survivors who are discharging 
home post-thrombectomy who were working and raising children prior to their acute 
stroke. Expanding inclusion criteria to include those older than 55 but younger than 
retirement age may yield important information for developing age-specific interventions.  
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Expansion of Variables and Questionnaires 
 Research in other neurological populations such as mild traumatic brain injury 
(TBI) indicate that survivors of mild TBI may experience similar symptoms. There are 
instruments designed to capture the presence of psychosocial symptoms in mild TBI 
patients that may apply to the YASS population of interest and this research. 
Additionally, this study did not include cognitive assessment of the YASS but based on 
some of the open-ended comments as well as literature addressing this population, there 
may be cognitive changes that can impact their recovery. 
 The volume, size or location of the infarct on initial and subsequent imaging (CT 
or MRI) was not collected. This information is readily available in the electronic medical 
record. The size or location of initial and residual infarcts may yield helpful information 
about the presence and severity of psychosocial variables and symptoms present in 
YASS. 
 Evaluation of the home environment including, levels of family and/or social 
support, may provide an important role in identifying keys to successful transition of 
YASS back to the community. Examining the post-discharge experiences of these YASS 
may provide more information on how to appropriately screen for discharge readiness 
and ongoing symptom detection and management.  
Prospective Enrollment and Multiple Time Points 
 In order to capture baseline levels of the psychosocial variables of interest (i.e. 
anxiety, fatigue, depression etc.) prior to stroke, as well as capture study participants 
responses at subsequent time points, enrollment prior to hospital discharge would be 
optimal. The majority of recruitment challenges in this study were related to inability to 
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contact patients post-discharge, therefore obtaining participant consent and contact 
information in-hospital may increase participation. Administration of questionnaires at 
set time points during YASS recovery, three months, six months, one year, 18 months 
and two years would yield more data and also allow comparison with other studies of 
YASS that used similar lengths of follow-up. This may benefit clinicians who would be 
able to target interventions to YASS at critical time points in their recovery. 
Additional Clinical Sites 
 In order to enroll more participants as well as those from a broad range of 
treatment sites, expanding enrollment to hospitals of varying size and geographical 
location would allow for a larger, more economically and culturally diverse study sample. 
Experiences may differ depending on support systems, provider perspective, and cultural 
background. Results from a more diverse and robust patient population would allow for 
generalizability of the findings. 
Summary 
The results of this study contribute new knowledge to the body of literature 
surrounding the experiences of YASS and the presence of psychosocial symptoms post-
acute thrombectomy for large vessel ischemic stroke. Despite superior functional 
outcomes post-thrombectomy, and the ability to discharge directly home from the acute 
setting, this group of YASS experienced psychosocial symptoms similar to other stroke 
patient populations, particularly post-stroke fatigue. These psychosocial symptoms were 
perceived as threatening to their lives in regards to treatment, concerns and emotions. The 
symptoms along with the threat may contribute to lower stroke specific quality of life.  
Additional findings suggested a lack of understanding of post-stroke symptoms among 
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this cohort of YASS. These YASS may be well enough to return home, but not yet well 
enough to return to normal life. These individuals may need a longer recovery period and 
offered support during the transition; for example, healthcare providers may have an 
opportunity to prescribe later return to work. To improve stroke recovery and quality of 
life for this population of YASS, tailored education and assessment of psychosocial 
symptoms is needed. 
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Appendix A 
Demographic Data Collection Tool 
 
 
Demographic Variables 
Age/ Sex/ Race 
Pre-morbid mRS/ Discharge mRS 
Arrival NIHSS/ Discharge NIHSS 
Clot location/vessel 
Alteplase administered 
TICI Score 
Date of stroke 
Years of education  
Working or FT student 
Contact Information 
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Fatigue Severity Scale 
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Stroke Specific Quality of Life Scale  
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Appendix E 
Brief Illness Perception Questionnaire 
For the following questions, please choose the number that best corresponds to your views. 
When answering, please think about symptoms since you had your stroke. 
How much do your symptoms affect your life? 
No affect at all                                  Severely affects my life 
 
0  1  2  3  4  5  6  7  8  9  10  
           
How long do you think your symptoms will continue? 
A very short time                                                           Forever 
 
0  1  2  3  4  5  6  7  8  9  10  
           
How much control do you feel you have over your symptoms? 
Absolutely no control                                        Extreme amount of control 
 
0  1  2  3  4  5  6  7  8  9  10  
           
How much do you think your treatment can help your symptoms? 
Not at all                                           Extremely helpful 
 
0  1  2  3  4  5  6  7  8  9  10  
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How much do you experience symptoms from your stroke? 
No symptoms at all                                  Many severe symptoms 
 
0  1  2  3  4  5  6  7  8  9  10  
           
How concerned are you about your symptoms? 
Not at all concerned                                     Extremely concerned 
 
0  1  2  3  4  5  6  7  8  9  10  
           
 
How well do you feel you understand your symptoms? 
Don't understand at all                                 Understand very clearly 
 
0  1  2  3  4  5  6  7  8  9  10  
           
How much do your symptoms affect you emotionally (do they make you angry, scared, 
upset or depressed)? 
Not at all affected emotionally                     Extremely affected emotionally 
 
0  1  2  3  4  5  6  7  8  9  10  
           
Please list in rank-order the three most important factors that you believed caused your 
symptoms. The most important factors for me: 
________________________________________________________________ 
________________________________________________________________ 
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APPENDIX F 
 
Georgia State University 
Informed Consent 
 
Title: Presence of psychosocial symptoms in young adult stroke survivors post-acute 
thrombectomy for ischemic stroke 
Principal Investigator: Dr. Dawn Aycock 
Student Principal Investigator: Karen B. Seagraves 
 
Purpose 
The purpose of the study is to investigate how you are feeling and what symptoms you 
may be experiencing after having a stroke. You are invited to participate because you 
were ages 18-55 at the time of your stroke, had a procedure to treat your stroke, and 
recovered well enough to discharge directly home from the hospital.  A total of 40 
participants will be recruited for this study.  If a follow up call is needed it will take 5 
minutes of your time. 
 
 
Procedures 
If you decide to take part, you will complete a series of 4 short questionnaires. The 
questionnaires are available through an email link or can be completed on paper and 
mailed back to the researcher. Participation will require 30 minutes of your time. 
Additionally, basic demographic information about you, as well as the size and location 
of the stroke, severity of your stroke symptoms at the time of your stroke and when you 
discharged from the hospital, will be obtained from your medical record.  
You may receive a follow up call after you submit your questionnaires if the researcher 
has a question about missing or hard to read answers, or to let you know if you have high 
scores on any of the questionnaires so you can share your symptoms with your primary 
care or neurology provider.  
 
Future Research 
Researchers will remove any information that may identify and may use your data for 
future research. If we do this, we will not ask for any additional consent from you. 
 
Risks 
In this study, you will not have any more risks than you would in a normal day of life. 
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Benefits 
This study is not designed to benefit you personally. This study will potentially assist in 
understanding psychosocial symptoms in this population and influence how patients are 
educated counseled and monitored for potential symptoms going forward. 
 
Compensation 
You will receive a $20 gift card for participating in this study.   
 
Voluntary Participation and Withdrawal  
You do not have to be in this study.  If you decide to be in the study and change your 
mind, you have the right to drop out at any time.  You may skip questions or stop 
participating at any time.  You may refuse to take part in the study or stop at any time, 
this will not cause you to lose any benefits to which you are otherwise entitled.  
 
Confidentiality  
We will keep your records private to the extent allowed by law.  The following people 
and entities will have access to the information you provide: 
 Dr. Dawn Aycock and Karen B. Seagraves 
 GSU Institutional Review Board 
 Office for Human Research Protection (OHRP)  
We will use a study participant number rather than your name on study records.  The 
information you provide will be stored on an encrypted flash drive in a locked file cabinet 
in a locked, private office. The code sheet that connect you to your study participant 
number will also be kept separately from the questionnaires that you complete, and the 
information from your medical record. All the study materials will be destroyed after the 
information is reported. Your name and other facts that might point to you will not appear 
when we present this study or publish its results. The findings will be summarized and 
reported in group form. You will not be identified personally. We will keep your personal 
information private.  Your privacy will be kept to the extent allowed by law. Data sent 
over the Internet may not be secure but we are suing a secure application and not 
collecting IP addresses. 
The health information you give us will be used in this research study.  We will remove 
all information that can identify you.  We will share it with other people for this research 
study.  If you decide you want to be in this study it means that you agree to let us use and 
share your personal health information for the reasons we have listed in this consent 
form. 
While we are doing this research, the research team may use only the personal health 
information that you have given us: your name, address, birthdate, etc..  The people and 
places that will be able to look at your personal health information are: Dr. Dawn Aycock 
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and Karen B. Seagraves.  They will look at it so they can work on this research study. We 
may also share your health information with the Georgia State University Institutional 
Review Board (IRB).  Your personal health information may be shared by the people or 
places we have listed, but it will be shared in a way that does not fall under the protection 
of federal regulations that apply to the privacy of health information.  This research may 
be shown to other researchers. This research may be published, but we will take steps to 
make sure that you cannot be identified. 
 
If you acknowledge this consent form by completing and returning the questionnaires you 
are letting us use your personal health information until the end of the study.  You have 
the right to say that you do not want us to use your personal health information after we 
have collected it.  If you decide you don’t want us to use your information anymore you 
must write a letter asking us not to use your information.  You will need to send the letter 
to the investigator who received your completed questionnaires.  This will be the only 
person who will be able to know which information is yours. 
 
 
Contact Information 
Contact Dr. Dawn Aycock at 404-413-1178 daycock@gsu.edu or Karen B. Seagraves at 
770-597-6110 kseagraves1@student.gsu.edu  
 If you have questions about the study or your part in it 
 If you have questions, concerns, or complaints about this study 
Contact the GSU Office of Human Research Protections at 404-413-3500 or irb@gsu.edu 
 if you have questions about your rights as a research participant 
 if you have questions, concerns, or complaints about the research. 
 
Consent 
You can print a copy of this consent form to keep or keep this paper copy of this form if 
you are completing the questionnaires on paper and mailing them. 
 
If you are willing to volunteer for this research, please click continue to proceed to the 
questionnaires, or please complete and return the paper questionnaires in the addressed, 
stamped envelope provided to you. 
 
 
 
 
